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ABSTRACT 
 
The Autoimmune Regulator (AIRE) contributes to central immune tolerance through the 
induction of self-antigen expression within the thymus. In humans, a defect in AIRE 
results in a multi-organ autoimmune disorder known as Autoimmune Polyglandular 
Syndrome Type-1. Both humans and mice with a deficiency in this gene develop 
autoreactive CD4+ T cells, serum autoantibodies and elevated rates of infertility. 
Interestingly, the pathology of autoimmune infertility in Aire-deficient (Aire-KO) mice 
differs between males and females. Ovarian autoimmunity causing a depletion of 
follicular reserves is prominent in female Aire-KO mice over 10 weeks of age. However, 
50% of mated six-week old female Aire-KO mice demonstrate embryo loss by 
embryonic day (ED) 7.5 despite having normal follicular reserves. We determined that 
ovulation (90% KO vs 100% WT; n=11), mating frequency (99% KO vs 100% WT; 
n>58), progesterone production (p=0.232; n=4) and decidualization are unaffected. 
However, 60% (9 of 15) of 6-8 week old Aire-KO female mice generated serum 
autoantibodies against the ovary and more frequently ovulated degenerated oocytes 
(31% KO vs 2% WT; n>71) When cultured, one-cell embryos from Aire-KO females 
failed to become 2-cell and blastocyst stage embryos at significantly reduced rate 
compared to WT controls (47% KO vs 76% WT and 19% KO vs 60% WT; n>67). 
Finally, embryos from Aire-KO dams are developmentally delayed at ED3.5 with a 
reduced trophectoderm outgrowth potential after 48 and 96 hours of culture  (0mm2 KO 
vs 7.1 mm2 WT, and 16.5 mm2 KO vs 30.9 mm2 WT; p<0.001, n=4). Alternatively, male 
Aire-KO mice have greater variability in the autoimmune targets associated with 
reduced fertility (18% KO vs 80% WT; n=10). Signs of disease included reduced 
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testosterone (p=0.03; n=18), loss of vomeronasal organ-associated glands (86% KO vs 
0% WT; n=7), prostatitis (90% KO vs 0% WT; n=20), epididymitis (75% KO vs 0% WT; 
n=20) and reduced in vitro fertilization rates (9% KO vs 54% WT; n>83 oocytes). 
Additionally a subset of males (23%; n=22) exhibited oligozoospermia with disruption of 
the blood-testis barrier. Collectively these results demonstrate the importance of central 
immune tolerance on fertility preservation by preventing autoimmune disease against 
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Preface 
 
The adaptive benefits allowing for embryonic development within the female womb 
(viviparity), which include continuous nourishment and environmental protection, 
simultaneously presents a unique immunologic challenge. Ideal reproductive outcomes 
that avoid maternal infection as well as fetal loss and disease require a modulation to 
the maternal immune system such that exposure to reproductive neo-antigens does not 
elicit a harmful immune response. These antigens, which derive from a range of 
sources including male gametes, seminal fluid, the developing embryo and placenta are 
intimately exposed to the maternal immune system through a variety of mechanisms 
and should be recognized as “foreign”. In analogous tissue transplantation models 
(Auchincloss & Sultan, 1996; Gould & Auchincloss, 1999) a similar level of genetic 
discrepancy without immunosuppression would lead to host rejection of the graft within 
a few weeks of the procedure. However, the reproductive and immune systems of 
placental mammals have co-evolved such that the developing fetus experiences an 
“immune-privileged” environment that ensures species survival. Understanding how this 
balance is maintained and then extending those insights into broader areas of 
transplantation medicine, autoimmune disease and reproductive biology has been a 
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The following introductory chapter will include a broad overview of male and female 
infertility separated by anatomic location and presented from a clinical perspective. Next 
I will introduce the immune system, its two main branches and the mechanisms 
responsible for stemming autoimmune disease including the role of the AutoImmune 
REgulator (AIRE) gene. I will then include a detailed description of the interface 
between the immune and reproductive systems as well as the known causes of 
autoimmune infertility related to the ovary, testis and epididymis. Finally, this chapter will 
conclude with a clinical presentation of the Autoimmune Polyglandular Syndrome Type-I 
(APS-1), which is a disease resulting from a deficiency in the AIRE gene. Importantly, 
APS-1 patients present with elevated rates of autoimmune gonadal insufficiency. The 
work documented within this thesis using an Aire-deficient mouse model is an attempt 
to address a gap in our knowledge regarding the role of central immune tolerance on 
fertility perseveration.  
 
INFERTILITY 
Infertility is an unfortunately common and complex condition that involves couples 
instead of individuals and has profound demographic, social, physiologic and medical 
implications. Studies dating back to the 1940’s (Guttmacher, 1956) as well several more 
recent ones (Gnoth, Godehardt, Godehardt, Frank-Herrmann, & Freundl, 2003; Slama 
et al., 2012; Zinaman, Clegg, Brown, O'Connor, & Selevan, 1996) have demonstrated 
two key parameters that characterize normal fertility. First, roughly 80-90% of couples 
who participate in regular intercourse will conceive over a 12 month duration and 
second, the reproductive potential (fecundity) of a female decreases with increased age. 
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While the precise numbers can vary by ethnicity and geographic location (Mascarenhas, 
Flaxman, Boerma, Vanderpoel, & Stevens, 2012), these estimates of normal fertility 
have in turn shaped the definition of infertility, which is the inability of a couple to 
conceive without the use of contraception over a period of 12 month in women under 
the age of 35, and six months in women over 35. Global estimates (Greenhall & 
Vessey, 1990) indicate that between 6-25% of couples meet the criteria for infertility or 
sub-fertility (reduced fertility with an extended period of non-conception). The reasoning 
for such variance is likely due to numerous factors including, but not limited to, survey 
methodology, geographic location, age of participants, primary vs. secondary infertility, 
inclusion of male infertility and the influence cultural stigma reporting accuracy. A more 
recent survey of 25 fertility population studies encompassing over 170,000 women 
(Boivin, Bunting, Collins, & Nygren, 2007), argued that the median prevalence of 
infertility worldwide was 9% in both developed and less-developed nations, of which 
56% and 22% were seeking, and had obtained, medical treatment respectively. A pair 
of 2013 prospective studies regarding fertility status of women in the United States 
between the ages of 15 and 44 concluded a slightly higher value (12-18%), but also 
suggest that percentage of females meeting infertility criteria have declined since 1982 
(Chandra A, 2013; Thoma et al., 2013). Regardless of a concrete value, the burden on 
the individual as well as the medical system is immense and likely to grow as factors 
including increased awareness and availability of assisted reproductive techniques, a 
desire to delay starting a family for personal or economic reasons and increased 
prevalence of sexually transmitted disease continue to broaden the percentage of 
individuals that could benefit from infertility treatment.   
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Causes of Infertility 
Compromised fertility was originally attributed to female pathologies. However, it is now 
appreciated that pregnancy complications can be multifactorial and originate from the 
female, the male, or both. Beginning in 1992 and updated in 2000, the World Health 
Organization (WHO) published the WHO Manual for the Standardized Investigation and 
Diagnosis of the Infertile Couple (Mahmoud, 2000), which, among many other things, 
categorized the various causes of infertility. While the precise numbers vary between 
publications, generalized estimates are as follows: 35% female factor only, 30% male 
factor only, 20% contributions from both partners and 15% unexplained (Forti & Krausz, 
1998; Hull et al., 1985).   
 
Female Infertility 
The following section will provide brief examples of pathologies leading to female 
infertility separated by anatomical location as their biology; medical evaluation and 
potential treatment options have been extensively reviewed elsewhere (Fiszbajn et al., 
2000; Forti & Krausz, 1998; Hamilton-Fairley & Taylor, 2003). 
 
Ovary 
The primary responsibility of the ovary is the storage, development and release of a 
mature ovum and conditions that reduce (oligoovulation) or prevent (anovulation) 
ovulation can impair fertility. There are numerous potential factors that can impinge on 
these processes, include genetic abnormalities, autoimmune disease, aging, premature 
ovarian failure, secondary effects of medications like chemotherapeutics and 
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antidepressants or antipsychotics (Haddad & Wieck, 2004). The classification system 
established by the WHO for female anovulatory infertility includes three unique 
categories as well as hyperprolactinaemia. 1) Hypogondaotropic hypogonadism: women 
with low levels of both pituitary and ovarian hormones. This category predominately 
reflects a pituitary disruption resulting in reduced levels of luteinizing hormone (LH), 
follicle stimulating hormone (FSH) and estradiol. Potential causes including very low 
body weight and extended periods of strenuous physical activity are more common than 
genetic causes including Kallman’s syndrome (a genetic disruption of Gonadotropin 
Releasing Hormone (GnRH) production) and Sheehan’s Syndrome (necrosis of the 
pituitary gland). 2) Normogonadotropic normoestrogenic: women with normal production 
of both pituitary and ovarian hormones. The majority of women within this category 
present with Polycystic Ovarian Syndrome (PCOS), a complex genetic and endocrine 
disorder associated with hirsutism, obesity and elevated levels of androgens and LH 
(Balen et al., 1995). PCOS is thought to result in excessive recruitment of pre-ovulatory 
follicles that do not respond to physiologic levels of FSH, ultimately blocking the 
complete development and release of an oocyte by the Graafian follicle. Some women 
with PCOS will sporadically ovulate, however the rarity of this event is such that the 
chance of becoming pregnant is significantly reduced. 3) Hypergonadotropic 
hypoestrogenic: women with elevated pituitary hormones in response to a lack of 
gonadal estrogen. This classification can be referred to “ovarian failure.” The resulting 
LH and FSH elevation can be either a component of normal menopause, which occurs 
at ~age 50, or “premature”, when it occurs alongside infertility in women < 40 years old. 
Genetic abnormalities may also cause hypergonadotropic hypoestrogenism. Early 
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detection in suspected cases of premature ovarian failure is important. The 
corresponding rise in FSH tends to precede complete ovarian exhaustion thus allowing 
for the possibility of fertility preservation through assisted reproductive intervention if 
diagnosed early. 
Importantly, ovarian senescence leading to hypergonadotropic hypogonadism is a 
natural part of the aging process. The full endowment of oocytes peaks during 
midgestation and steadily declines over the lifetime of women until follicular reserves 
are depleted at menopause (Richardson, Senikas, & Nelson, 1987). However, fertility 
success diminishes prior to a complete absence of the female gamete as shown in a 
2008 study from the Center for Disease Control which compared live birth rates 
following Assisted Reproductive Technologies (ART) using a patient’s own eggs vs. 
donated ones as a function of age (Sunderam et al., 2013). The report showed that live 
birth rates from women using their own eggs between the ages of 35 and 45 
continuously declined from 45% to 5%. Comparatively, the percentage of live births 
from women using donated eggs remained constant at >50% regardless of age. This 
age related decrease in fecundity is likely the result of lower egg quality, as well as 
quantity, leading to increased rates of meiotic disjunction failure producing 
chromosomal imbalances that block embryonic development (Broekmans, Soules, & 
Fauser, 2009).  
 
Tubal-peritoneal  
The Fallopian tubes are the location of several essential reproductive events including 
oocyte uptake, fertilization within the ampulla and early embryonic development prior to 
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passage into the uterus. Consequently, tubal disorders or local pelvic adhesions have 
the potential to impair fertility by preventing the normal transport of gametes. It is 
currently estimated that 25-30% of female infertility can be attributed to a tubal factor 
with the majority of cases involving an infectious pathogen leading to Pelvic 
Inflammatory Disease (PID) (Akande et al., 2003) as opposed to a congenital defect 
(Forti & Krausz, 1998).  
 
Uterus 
The hormonally primed and receptive uterus ultimately provides nutrients and protection 
for the growing fetus by facilitating implantation as well as placental and embryonic 
development. Anatomic or congenital uterine defects that impinge on implantation have 
the potential to reduce fecundity. Anatomic defects include intrauterine polypus, 
adhesions and neoplasias. Müllerian duct abnormalities represent a collection of 
congenital defects stemming from incomplete development, formation and/or fusion of 
the mesonephric ducts. It is currently estimated that these deformities impact 
approximately 3.8% and 6.2% of fertile and infertile females respectively, and are 
associated with recurrent pregnancy loss and preterm birth (Rackow & Arici, 2007; 
Raga et al., 1997).  
 
Endometriosis 
Endometriosis (Sampson, 1927) is a common and chronic disorder whose 
pathogenesis, incidence rate and ideal medical management are still being investigated. 
A complete diagnosis relies on the discovery of extra-uterine endometrial implants on 
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the ovaries or within the pelvic peritoneal cavity. Clinically, the condition is described as 
an estrogen-dependent inflammatory disease that often presents with pelvic pain, 
painful intercourse and elevated infertility rates (Falcone & Lebovic, 2011). However, 
the disease can be either asymptomatic or associated with a diverse range of 
symptoms (Rawson, 1991), therefore making the establishment of an incidence rate 
difficult. Current estimates suggest that 5-10% of the general female population has 
some degree of endometriosis and that the incidence rate is significantly elevated to a 
range of 25-40% in women with infertility (Strathy, Molgaard, Coulam, & Melton, 1982). 
  
Cervix 
The cervix and its mucosal lining are important for the transport of sperm to the site of 
fertilization. Ascending infections of the cervix and vagina have the potential to block 
mucus production or alter its pH range, both of which can inhibit sperm motility (Lai et 
al., 1997; Paavonen & Eggert-Kruse, 1999). Additional causes of infertility related to the 
cervix include trauma, congenital defects and the presence of anti-sperm antibodies 
within the mucus (Moghissi, Sacco, & Borin, 1980).  
 
Genetic 
The incidence of a genetic based cause of infertility is higher in men than women (Mau-
Holzmann, 2005). In addition to the two predominate genetic causes of female infertility, 
Turner’s Syndrome and PCOS, there are other single gene mutations associated with 
impaired fecundity. The majority of these genes are associated with the hypothalamic-
pituitary (HPG) axis or steroidogenesis and consequently impair both female as well as 
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male infertility. Examples include mutation to the Kisspeptin receptor (GPR54) 
(Colledge, 2009), Gonadotropin-releasing hormone receptor (GnRH-R) (Cattanach, 
Iddon, Charlton, Chiappa, & Fink, 1977), Luteinizing hormone receptor (LH-R) (Arnhold, 
Latronico, Batista, & Mendonca, 1999) Follicle stimulating hormone receptor (FSH-R) 
(Lussiana et al., 2008), Steroidogenic factor 1 (SF-1) (Bashamboo et al., 2010) and 
fragile X mental retardation 1 (FMR1) (Wittenberger et al., 2007) (fragile X-syndrome).  
 
Male Infertility 
A complete evaluation of the infertile couple must include the male partner as it is 
currently estimated that 50% of infertility cases have a male specific component 
(Mahmoud, 2000). A male infertility assessment often begins with a semen analysis to 
address both quantity and quality. Many infertile and sub-fertile males will present some 
combination of oligo/azoospermia (decreased/no sperm in the ejaculate) with either 
asthenozoospermia (decreased motility) or teratozoospermia (abnormal morphology) or 
both. Unfortunately the assessment of male infertility is confounded by three factors. 
First, the primary clinical evaluation relies heavily on semen analysis using a light 
microscope, which can be vulnerable to both observer subjectivity and variability (H. W. 
Baker et al., 1981). Second, some infertile males display no abnormalities in quantity, 
morphology or motility. Finally, while an estimated 50-60% of infertilities can be 
categorized into disorders related to the hypothalamus/pituitary, testis or post-testicular 
sperm transport, this still leaves nearly half of male infertility cases with the diagnosis of 
idiopathic (de Kretser, 1997).  
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Pre-Testicular disorders 
Male fertility involves a series of events beginning with testicular sperm development 
(spermatogenesis), epididymal sperm maturation/storage, contribution from accessory 
gland secretions and culminating with intercourse. Essential to many of these processes 
are downstream effects of gonadotropin signaling. Disruptions of hypothalamic GnRH or 
pituitary LH and FSH can produce secondary hypogonadism and infertility. Secondary 
hypogonadism, which is clinically distinguished by the combination of oligozoospermia, 
low serum testosterone and low or low-normal levels of LH and FSH, can originate from 
congenital, acquired or systemic illnesses.  
Congenital secondary hypogonadism is typically due to Kallman’s syndrome (MacColl, 
Quinton, & Bouloux, 2002) and afflicted patients present with eunuchoid habitus (small 
external genital, little or no body hair and low testicular volume). Other potential genetic 
alterations that can impair pituitary gonadotropins include mutations to GPR54 (de Roux 
et al., 2003), GNRH1 (Bouligand et al., 2009), leptin/leptin-receptor (Clement et al., 
1998) and the β-subunits of LH/FSH (Phillip, Arbelle, Segev, & Parvari, 1998; Weiss et 
al., 1992). 
Acquired disorders that impinge on the hypothalamic-gonadal (HPG) axis typically result 
in physical symptoms that are less dramatic than congenital disorders, but include 
asthenia as well as decreased libido, facial hair and ejaculate volume. The origin of 
acquired diseases are vast but the outcomes are typically separated into three 
categories; first, the destruction of GnRH neutrons or pituitary gonadotrophs, second, 
the functional suppression of GnRH or gonadotropin release, or third, the infringement 
of the hypothalamic-pituitary portal circulatory system. Examples resulting in functional 
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destruction include hypothalamic/pituitary tumors or cysts (Citron et al., 1996) as well as 
infiltrative disease like Sarcoidosis (Porter, Beynon, & Randeva, 2003). Alternatively, 
suppression of the hypothalamic-pituitary axis can result from hyperprolactinemia, 
prolonged opioid therapy (Daniell, 2002), chronic glucocorticoid use (MacAdams, White, 
& Chipps, 1986) and artificially elevated gonadal steroids (Turek, Williams, Gilbaugh, & 
Lipshultz, 1995). Finally, a disruption of the pituitary portal circulatory system, which 
prevents GnRH from reaching the pituitary or gonadotropins from entering systemic 
circulation, is usually caused by physical trauma, surgery or vascular infarction. 
In addition to local effects on the hypothalamus or pituitary, there are systemic illnesses 
and nutritional conditions that can cause secondary hypogonadism. Examples of 
chronic illness include cirrhosis (Green, 1977), diabetes mellitus type 2 (Dhindsa et al., 
2004) and renal failure (Albaaj et al., 2006). Additionally, severely altered nutritional 
statuses like anorexia nervosa and obesity (BMI 30 ≥kg/m2) correlate with reduced 
fertility and low serum testosterone levels (Strain et al., 1982).  
 
Primary gonadal 
Primary hypogonadism results from diseases that directly affect the testis and have the 
potential to reduce serum testosterone and sperm quantity. Clinically, primary 
hypogonadism is distinguished from secondary by the corresponding elevation of both 
LH and FSH. However, presenting symptoms vary based on the cause of the disease 
and more importantly, if and when the loss of testosterone occurs. Additionally, male 
patients have a higher prevalence of gynecomastia due to the sustained increase in 
gonadotropins, which allows aromatase activity and consequently estrogen levels to rise 
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(R. E. Johnson & Murad, 2009). Finally, testicular disease, which can have genetic, 
environmental, infectious, physical and systemic origins, is estimated to provide the 
largest contribution to known causes of male-infertility at 30-40% (Mahmoud, 2000).  
The estimated range of genetic abnormalities in males with primary hypogonadal 
infertility is between two and eight percent. However, the association can increase to as 
much as 24% in azoospermic males (Dohle et al., 2002), with Klinefelter’s Syndrome 
(KS) being the single largest contributor (Kamischke, Baumgardt, Horst, & Nieschlag, 
2003). Other chromosomal abnormalities associated with male infertility include 46 
XY/XO (Jackson, Hoffman, & Makda, 1966), various sex-chromosome translocations 
(Frydman et al., 2001; Guichaoua et al., 1990) and microdeletions within the Y-
chromosome. The Yq11 region of the long arm of the Y-chromosome contains genes 
essential for spermatogenesis. The region, also known as the azoospermic factor 
(AZF), is subdivided into three parts (AZFa, AZFb and AZFc) (Tiepolo & Zuffardi, 1976; 
Vogt et al., 1996). Deletions impacting multiple genes within the AZFb and AZFc 
regions are more common than those within AZFa, due to large repetitive sequences 
(Krausz et al., 2006; Kuroda-Kawaguchi et al., 2001). While the exact role of AZF genes 
in spermatogenesis remains unclear, it is estimated these microdeletions contribute to 
approximately 10-15% of male infertility that present with severe oligozoospermia, 
azoospermia or Sertoli cell only syndrome (Martinez et al., 2000).   
In addition to large-scale chromosomal abnormalities there are several single gene 
mutations that can impair male fertility. Some examples include mutations or 
polymorphisms to the genes responsible for the androgen receptor (Hiort et al., 2000), 
LH receptor (Latronico et al., 1996), FSH receptor (Tapanainen, Aittomaki, Min, 
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Vaskivuo, & Huhtaniemi, 1997), cystic fibrosis transmembrane conductance regulator 
(CFTR) (Cuppens & Cassiman, 2004), deleted in azoospermia-like (DAZL) (Teng et al., 
2002), synaptonemal complex protein 3 (SYCP3) (Miyamoto et al., 2003) and insultin 
like 3 (INSL3) (Foresta & Ferlin, 2004). Finally, congenital disorders whose 
pathogenesis cannot be attributed to a single gene include cryptorchidism 
(undescended testes), testicular cancer and varicoceles (dilations of the pampiniform 
plexus).   
Acquired testicular conditions can alter male fertility; however, the severity and 
associated symptoms vary depending on the causative agent, the timing of onset and 
whether sperm production, testosterone secretion or both are impaired. Several 
infectious conditions can result in infertility secondary to testicular inflammation 
(orchitis). Bacterial orchitis, often the result of a sexually transmitted infection (STI), 
typically begins as an epididymal infection that spreads to the testis (epididymo-orchitis) 
(Gonzales et al., 2004).  Alternatively, viral orchitis is commonly derived from a mumps 
infection in post-pubertal males. Approximately one third of adult males that contract 
mumps will experience testicular involvement. In general, orchitis impairs male fertility 
through germ-cell disruption (Beard, Benson, Kelalis, Elveback, & Kurland, 1977).  
A second significant source of acquired conditions that are harmful to male fertility 
includes exposure to various environmental and chemical agents. These products can 
impair spermatogenesis or androgen production with the extent of the damage being 
related to both dosage and duration. The sensitivity of the male reproductive system to 
environmental agents has been well documented (Spira & Multigner, 1998) and 
originates with case studies from the late 1970’s involving the pesticide nematocide 
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(1,2-dibromo-3-chloropropane) (Whorton, Krauss, Marshall, & Milby, 1977). Other non-
pesticide toxicants that can impair male fertility include ionization radiation (Ash, 1980) 
and alkylating/anti-neoplastic drugs like cyclophosphamide and cisplatin (Dohle, 2010).  
A third source of acquired testis-specific male infertility results from physical conditions. 
Examples include direct testicular trauma, bilateral orchiectomy, hyperthermia and 
testicular torsion. 
Finally, many of the systemic illnesses, like cirrhosis (Green, 1977) and chronic renal 
failure (Albaaj et al., 2006), which cause secondary hypogonadism can also directly 
affect the testis. Other examples include men with HIV and sickle cell anemia. HIV 
positive patients, though fertile, tend to have lower testosterone levels (without the 
corresponding elevation in gonadotropins) compared to non-infected males (Dobs, 
Dempsey, Ladenson, & Polk, 1988; Sellmeyer & Grunfeld, 1996), whereas those with 
sickle cell anemia are often infertile, presumably due to testicular ischemic injury 
(Abbasi, Prasad, Ortega, Congco, & Oberleas, 1976). 
The various biologic and molecular pathways involved in male sex determination, 
puberty onset and spermatogenetic development are extremely complex, and in many 
cases, still being investigated (McElreavey, Barbaux, Ion, & Fellous, 1995; Phillips, 
Gassei, & Orwig, 2010). Often these gaps in knowledge result in an ability to identify the 
target of the disorder but prevent a full understanding of disease etiology and 
pathogenesis. The consequence is that many cases of testicular-based infertility are 
diagnosed as idiopathic.  
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Post-testicular sperm transport  
Spermatozoa entering the epididymis are both non-motile and incapable of fertilizing a 
female oocyte. During transit through the epididymal tubules, male sperm cells 
complete their maturation and are eventually stored in the caudal portion of the 
epididymis. During an ejaculatory event, caudal sperm pass through the vas deferens, 
are diluted by secreted products from the prostate, seminal vesicle and bulbourethral 
gland and eventually exit through the urethra.  
Disorders that alter the ability of the epididymis to facilitate the later stages of sperm 
maturation, concentration and storage have the potential to impair fertility. Examples 
include bacterial sexually transmitted infections as well as other non-infectious 
abnormalities like trauma, vasectomy and neoplasia. Unfortunately, the current 
understanding of the conditions that impact the epididymis and their consequences is 
limited. The reasoning for this is two-fold; first, epididymitis, which is the most common 
intra-scrotal infection, only impacts approximately 0.4% of US males annually (Trojian, 
Lishnak, & Heiman, 2009) and second, disorders of the epididymis rarely impair 
spermatogenesis and therefore the ART of Intracytoplasmic sperm injection (ICSI) is 
still a viable option to maintain male fertility.  
 
Lifestyle 
The cumulative behavioral choices one makes appears to alter fecundity in both males 
and females. While the topic is still under investigation, there is variety of “lifestyle” 
factors that should be considered when assessing fertility complications. First, tobacco 
use in men can decrease sperm quality parameters including concentration and motility 
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(Vine, Margolin, Morrison, & Hulka, 1994) whereas in women, smoking more than 10 
cigarettes per day is associated with an increased time required to become pregnant (D. 
D. Baird & Wilcox, 1985). Second, a Body Mass Index (BMI) above or below the normal 
range (18.5-25 kg/m2) is statistically associated with anovulatory infertility in women and 
altered reproductive hormone levels in men (Clark et al., 1995). Third, prolonged 
strenuous exercise, particularly in females, is associated with infertility that is likely 
secondary to altered HPG axis hormone levels (Cannavo, Curto, & Trimarchi, 2001; 
Roupas & Georgopoulos, 2011). Forth, excessive alcohol consumption (≥ 14 drinks per 
week) is associated with increased times to become pregnant (Jensen et al., 1998), 
altered spermatogenesis (Pajarinen & Karhunen, 1994) and lower In Vitro Fertilization 
(IVF) success rates (Klonoff-Cohen, Lam-Kruglick, & Gonzalez, 2003). Finally, other 
“lifestyle” factors like caffeine intake, sexual behavior, environmental toxicant exposure, 
diet and stress are frequently mentioned in discussions regarding infertility but no clear 
consensus as to their mechanism of action has been established.  
 
Unexplained  
Unfortunately 15% of infertility cases fail to produce a definitive diagnosis. In these 
situations a single or a combination of slightly altered biologic properties is the most 
commonly offered rationale. Possibilities include mild decreases in sperm or egg quality 
(Lass et al., 1997), reduced semen quantity (Aitken, Best, Warner, & Templeton, 1984), 
impaired sperm/egg interaction (Tesarik & Testart, 1989) and incomplete ovarian 
luteinization (Li, Lenton, Dockery, & Cooke, 1990). While this diagnosis can be 
understandably frustrating, unexplained infertility is often not absolute as nearly 30% of 
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infertile women will become pregnant within a three-year window following diagnosis 
even without medical intervention (J. A. Collins, Burrows, & Wilan, 1995; Snick, Snick, 
Evers, & Collins, 1997). Additionally, assisted fertility counseling and treatments can 
improve prognosis. Options ranges from lifestyle adjustments (maintaining a normal 
body mass index (BMI = 20-27 kg/m2), limiting caffeine, alcohol and smoking) to clinical 
intervention (clomiphene-induced ovulation with IVF) (Pandian, Gibreel, & Bhattacharya, 
2012).  
 
The reproductive system, and by extension, fertility success, is dependent upon 
cooperative interactions with other systems within the body including the immune 
system. The immune system is not only responsible for the efficient removal of 
infectious agents, but is also integral to many normal physiologic functions. 
Inappropriate activation of the immune system can produce many human diseases. The 
following sections will provide a background on the general principles of the immune 
system, its involvement with normal reproductive physiology and conclude with 
examples of immune disorders that impair human fertility.  
 
THE IMMUNE SYSTEM 
The immune system is a network of cells and organs broadly divided into two categories 
(innate and adaptive) that work together to protect a host against invasion from the 
multitude of potentially pathogenic microorganisms that share our environment. In the 
event of an infection, the immune system recognizes, responds and remembers the 
responsible foreign antigen such that the initial as well as any subsequent infection by 
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that pathogen can be eradicated.  
 
Innate Immunity 
Pattern Recognition Receptors and Pathogen Associated Molecular Patterns 
The innate branch of the immune system, which is evolutionarily the oldest, is 
essentially the first line of host defense. It relies on a limited repertoire of germline-
encoded receptors known as Pattern Recognition Receptors (PRR) that recognize and 
respond to highly conserved molecular motifs known as Pathogen Associated Molecular 
Patterns (PAMPs) found on various pathogens but absent within the host. This is a 
simple method allowing for a rapid distinction of harmless self from infectious non-self 
during the initial phase of an infection. The PRRs are broadly separated into two 
categories; secreted and cell associated. The circulating forms of pattern recognition 
receptors allow for direct microbial toxicity, increased phagocytosis (opsonization) and 
work synergistically with other transmembrane PRRs. While the list of secreted PRRs is 
extensive, they can be broadly grouped into antimicrobial peptides (Zasloff, 2002), 
pentraxins (Garlanda, Bottazzi, Bastone, & Mantovani, 2005), lectins (Holmskov, Thiel, 
& Jensenius, 2003) and collectins (Holmskov, Malhotra, Sim, & Jensenius, 1994; 
Holmskov et al., 2003). Alternatively, membrane bound pattern recognition receptors 
are constitutively expressed at the plasma membrane and on intracellular vesicles of 
many of the innate immune cells as well as by professional antigen presenting cells (B 
cells, monocytes/macrophages and dendritic cells). Engagement of these cell-
associated receptors triggers an immune response by activating pathways that increase 
PRR expression, facilitate phagocytosis and stimulate the release pro-inflammatory 
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cytokines, chemokines and type I interferons. The classic transmembrane PRRs are the 
family of Toll-like receptors (TLRs) (Akira & Takeda, 2004; Takeda, Kaisho, & Akira, 
2003) which are broadly expressed across several cell types, including dendritic cells, 
macrophages, epithelial cells and neutrophils, can recognize a variety of PAMPs 
including nucleic acids, proteins and portions of microbial cell walls and have domains 
that are highly conserved across species (O'Neill & Bowie, 2007; Yamagata, Merlie, & 
Sanes, 1994). Additional cell-associated PRRs include Rig-1 like receptors (Yoneyama 
& Fujita, 2007) and C-type lectins.  
 
Cells of the Innate Immune System 
Cells of the innate immune system are defined by their expression of PRRs and serve 
many different immune functions. Epithelial and mast cells reside in regions of high 
antigen exposure and provide a sentinel role. Stimulation of their PRRs results in the 
production of proinflammatory cytokines like TNF-α and IL-8 and other immune 
mediators including histamines, leukotrienes and proteases. Neutrophils, 
monocytes/macrophages and natural killer cells provide the effector functions of the 
innate immune system. Neutrophils (Mantovani, Cassatella, Costantini, & Jaillon, 2011), 
which are the most abundant circulating phagocyte, are the initial immune component 
recruited to a site of inflammation. Activated neutrophils phagocytize opsonized 
microbes and attempt to destroy them within the phagosome via reactive oxygen 
species (ROS), proteases and other anti-microbial products. Bone marrow derived 
monocytes complete differentiation into macrophages upon entering into a tissue. 
Similar to neutrophils, they phagocytize and destroy microbes, but also provide 
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additional immune functions including antigen presentation (Martinez-Pomares & 
Gordon, 2007) and the secretion of a much larger repertoire of inflammatory products 
(Takemura & Werb, 1984). Natural killer cells (NK cells), although derived from the 
lymphoid lineage, are still a component of the innate immune system. Besides the 
standard set of PRRs, NK cells have an additional battery of activating and inhibitory 
receptors (Lanier, 1998) that regulate and preferentially direct their response towards 
cells that are virally infected or malignant.  
 
Communication between the Innate and Adaptive Immune System 
The two branches of the immune system are distinguished by their developmental 
lineage and the origin of their antigen recognition receptors. But they do not function 
independently of one another. PAMP recognition by the innate immune system can both 
activate antigen presentation pathways and function as an adjuvant, thereby alerting the 
adaptive immune system to a pathogen and generating a sustained vigorous response. 
The dendritic cell (DC) is arguably the most important cellular mediator of 
communication between the innate and adaptive immune systems. DCs become 
activated through direct recognition of PAMPs and exposure to proinflammatory 
cytokines including type I interferons and IL-12 (Langenkamp, Messi, Lanzavecchia, & 
Sallusto, 2000). This maturational process facilitates key events including phagocytosis 
and destruction of microbes; the upregulation of cytokine receptors, major 
histocompatibility complex (MHC) II molecules, and costimulatory molecules (CD80 and 
CD86); and the subsequent presentation of antigens derived from phagocytosed 
microbes. Activation culminates in the migration of the mature DC from the initial site of 
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inflammation to a draining lymph node where it can initiate an adaptive immune 
response by presenting antigen to naïve T cells (Stoll, Delon, Brotz, & Germain, 2002). 
Importantly, this communication pathway is not unidirectional, as effector products 
released from activated lymphocytes can influence the cellular response of DC through 
feedback signaling pathways. This concept is illustrated by the following examples. 
First, opsonization of microbes by specific B cell generated antibodies aids in efficient 
phagocytosis by innate immune cells. Second, activated T cells secrete IFN-γ that feeds 
back on macrophages to enhance their ability to eliminate microbes by stimulating 
enzyme pathways that reduce ROS into superoxide radicals.  
 
Adaptive Immunity  
The adaptive immune system evolved as a mechanism of host defense in response to 
various pathogens that developed the ability to evade innate immunity. Key features of 
the adaptive immune system that are distinct from innate immunity include near limitless 
antigen specificity and immunologic memory.  
 
Humoral Immunity 
B Cell Development 
Humoral (non-cellular component of blood) immunity refers to immune defense 
mediated by antibodies, which are the secreted effector product of mature and activated 
B cells. B cell development first occurs in the fetal liver and is gradually transitioned to 
the bone marrow at around 12 weeks of gestation (Hardy & Hayakawa, 2001). The 
creation of a B cell from a common lymphoid progenitor involves a series of highly 
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regulated steps controlled by lineage-specific growth factors, transcription factors and 
enzymes. Further, the transition between stages requires the successful rearrangement 
and expression of the Ig (immunoglobulin) heavy and light chains that constitute the B-
cell Receptor (BCR), which is in essence a membrane-bound antibody. In brief, the first 
stage of B cell development (pro-B cell) is initiated by extrinsic factors including IL-7, 
stem cell factor and IGF-1 and results in the intracellular expression of recombinase 
activating genes (RAG) 1 & 2 and the membrane expression of CD19. Transition to the 
pre-B cell stage occurs when the RAG genes complete a successful V-D-J 
recombination (Brack, Hirama, Lenhard-Schuller, & Tonegawa, 1978; Schatz, 2004) of 
the Ig heavy chain, which is then expressed (along with a surrogate light chain) at the 
cell surface. Other key markers of this stage include expression of CD40 and TdT 
(terminal deoxytransferase). Finally, the pre-B cell becomes mature when the Ig light 
chain is rearranged and combined with the heavy chain to generate an IgM molecule 
that is expressed at the cell surface. Mature B cells, still within the bone marrow, that 
have a high affinity for self antigens can attempt to edit their antigen receptor (Tiegs, 
Russell, & Nemazee, 1993) through a reactivation of the V(D)J recombination process. 
It is estimated that nearly half of all peripheral B cells have activated this mechanism of 
receptor editing in order to assemble an Ig that is nonresponsive to autoantigens (Retter 
& Nemazee, 1998). B cells with Ig receptors that are ignorant of self-antigens leave the 
bone marrow and migrating to secondary lymphoid organs like the spleen, tonsils and 
lymph nodes, whereas those with Ig receptors that are still specific for self-antigens are 
removed via apoptosis (negative selection).  
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B cell Activation 
Activation of a mature/resting naïve B cell requires two initial stimulatory signals. First is 
the simultaneous engagement of multiple B cell receptors. The second is a cooperative 
signaling event from either circulating cytokines or cell-cell contact. The consequence of 
B cell activation depends on the type of antigen driving the response and whether or not 
it is the initial exposure to that antigen. Type I and II Thymus-Independent (T-
Independent) antigens are typical polysaccharides that activate B cells through intrinsic 
repeated structural motifs and produce a response that is generally low affinity, IgM-
based and creates little to no immunologic memory. Thymus-Dependent (T-dependent) 
antigens are protein in origin and rely on cooperation between B and T cells to create a 
polyclonal, high affinity response that produces long-lived immunologic memory (Stein, 
1992).  
The steps involved in the T-dependent activation and maturation of a naïve B cell during 
a primary immune response are quite extensive and well-reviewed (Baumgarth, 2000; 
Parker, 1993). Briefly, an antigen-activated T cell within a lymph node will recognize an 
activated B cell presenting the same antigen on its surface in the context of an MHC 
molecule. The T cell will provide the secondary activating signal through ligation of the 
cell surface molecules CD40-CD40L. These signaling events induce B cell 
hyperproliferation within a germinal center and led to Ig class switching and 
hypermutation through the activation of the DNA altering enzyme activation-induced 
cytosine deaminase (AID). The end result is expanded populations of B cells that make 
different subclasses of Ig molecules with high affinity for the stimulating antigen.  
Mature B cells have three basic fates. Most mature B cells are lost in the germinal 
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center to unsuccessful affinity maturation of the Ig molecule wherein they no longer 
recognize the stimulating antigen. Second, a percentage of B cells with a productively 
rearranged Ig molecule will differentiate into plasma cells, migrate to the bone marrow 
and secrete large amounts of circulating antibodies. During the primary response, the 
time from initial exposure to production of high affinity, class-switched antibodies can 
take nearly two weeks. Finally, a small percentage of the stimulated B cells will 
differentiate into CD27+ memory B cells (Klein, Rajewsky, & Kuppers, 1998) that can 
survive for decades. Upon subsequent exposures, memory B cells commence a 
secondary immune response by rapidly differentiating into plasma cells that release 
high affinity antibodies. Compared to a primary response, the secondary immune 
response is much faster and more robust.    
 
Cellular Immunity 
T Cell Development 
The majority of circulating T cells complete their development within the thymus and 
express a T cell receptor (TCR), which is composed of a heterodimer of an α and a β 
chain (Garcia et al., 1996). Early T cell progenitors are first detected in the fetal liver 
around the sixth week of gestation (McCune et al., 1988; Touraine, Roncarolo, Royo, & 
Touraine, 1987); by the end of the second trimester, hematopoietic development 
transitions to the bone marrow (Haynes, Martin, Kay, & Kurtzberg, 1988; Spits, Lanier, 
& Phillips, 1995). These bone marrow-derived progenitors migrate hematogenously to 
the thymus, where they enter through high endothelial venules at the corticomedullary 
junction and gradually migrate to the outer cortex (Kwan & Killeen, 2004). Within the 
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thymus, specialized epithelial cells control the recruitment, development, expansion and 
differentiation of early T cell progenitors through cell-to-cell contact, which activates the 
notch-signaling pathway, and a variety of secreted products including IL-7, thymopoietin 
and thymulin (Takahama, 2006). Briefly, immature T cells within the cortex undergo a 
massive IL-7-dependent expansion, and expression of the cluster of differentiation (CD) 
markers CD7, CD1 and CD2 is induced. At this stage, cortical T cells are ‘double 
negative’ (DN), i.e., they lack expression of both of the CD4 and CD8 co-receptors.  
These DN thymocytes progress through four stages that are identified by the differential 
expression of CD44 (E-selectin ligand) and CD25 (IL-2 receptor alpha chain) (Starr, 
Jameson, & Hogquist, 2003). A key event during these DN stages is RAG-dependent 
recombination of the TCR beta chain, followed by surface expression of the pre-TCR 
together with the lineage-specific CD3 co-receptor complex. Signaling through the pre-
TCR promotes several important outcomes including cell survival, further differentiation, 
allelic exclusion of the TCR beta chain (Borgulya, Kishi, Uematsu, & von Boehmer, 
1992), recombination of the TCR alpha chain and the co-induction of CD4 and CD8. 
Finally, “double positive” (DP) thymocytes experience positive selection (see below) in 
the cortex before migrating to the medulla where T cells complete maturation by 
undergoing negative selection (see below) and acquiring the singular expression of 
either CD4 or CD8. Ultimately, only 2-5% of T cells complete this process and provide 
peripheral immune surveillance. 
 
T Cell Activation 
The specific activation of T cells to eradicate an infection requires a controlled series of 
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events. Professional antigen presenting cells (APC), become activated by ligation of 
their inflammatory cytokine receptors and PRRs. Activated APCs migrate from the site 
of infection to a draining lymphoid organ where they present acquired antigens in the 
context of MHC I and II molecules to naïve T cells. MHC restriction ensures the 
activation of an appropriate T cell subset (see below) for a given infection. Class I MHC 
is critical for identifying virally infected cells by presenting peptides derived from 
intracellular proteins to CD8+ T cells. Class II MHC molecules, which are selectively 
expressed on professional APCs, present peptides from phagocytized microbes to 
CD4+ T cells to fight extracellular infections. The power of the adaptive immune system 
resides in its specificity. The variable recombination of the V, D and J gene segments 
(Schatz, 2004) of the TCR by RAG-1 and -2 allow for a theoretical limit of 2.5x107 
different antigen receptors (Casrouge et al., 2000). Specific antigen/MHC recognition by 
a unique complementary TCR induces intracellular signaling pathways leading to 
proliferative clonal expansion and the expression of co-stimulatory molecules and 
subset specific effector genes (see below). Similar to B cells, T cells require two linked 
stimulatory signals for a successful activation. The CD3 complex, which is non-
covalently associated with the TCR, provides the initial signal in response to antigen 
recognition. The second co-stimulatory signal for T cell activation is provided through 
the ligation of CD28 on T cells with CD80 and CD86 molecule on APCs (Fujii, Liu, 
Smith, Bonito, & Steinman, 2004). These activation signals result in the upregulation of 
CD154 on T cells which binds to CD40 on macrophages, endothelial cells and B cells 
resulting in cellular activation and, in the case of B cells, affinity maturation and Ig class 
switching (Grewal & Flavell, 1998).  
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T Cell Subsets  
Mature T cells are broadly separated into two categories: cytotoxic T cells, which 
mediate an immune response via direct cellular contact and modulatory T cells, which 
either activate or repress lymphocytes by secreting various cytokines. Cytotoxic T cells 
(Tc) are MHC class I restricted due to expression of the co-receptor CD8. Upon 
activation, Tc cells reenter the circulatory system in search of infected cells to synapse 
with and induce apoptosis through the Fas-FasL (Ju et al., 1995) pathway or, 
alternatively, through the release of granules loaded with perforin and granzymes.  
CD4+ T cells, which are MHC class II-restricted, are separated into four main effector 
groups (Th1, Th2, Th17 and Treg) based on their cytokine secretion profiles. T helper 
(Th) 1 cells, which release IL-2, IL-3, IFN-γ and TNF, are responsible for fighting 
intracellular infections by activating macrophages and cytotoxic T cells and by 
promoting B cell differentiation into antibody-secreting plasma cells. Th2 cells help fight 
parasitic infections by releasing cytokines and chemokines that recruit eosinophils and 
by inducing plasma cell production of IgE. Th17 cells (Harrington et al., 2005) are 
typically associated with chronic autoimmune inflammatory syndromes and develop 
after prolonged exposure to IL-6, TGF-beta and IL-1beta. These cells predominately 
secrete the proinflammatory cytokines IL-17, IL-22 and IFN-γ. Finally, T regulatory cells 
(Sakaguchi, 2004; Sakaguchi, Sakaguchi, Asano, Itoh, & Toda, 2011) (Tregs), are 
defined by expression of CD25 and the transcription factor Foxp3 (Hori, Nomura, & 
Sakaguchi, 2003), can develop de novo in the thymus or can be induced in the 
periphery, and serve as powerful suppressors of the immune system through release of 
IL-10 and TGF-beta (see below).  
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Mechanisms of Immune Tolerance  
Regulation of mature lymphocytes is a constant and dynamic process that permits an 
immune response against harmful non-self while stemming immune recognition of 
harmless self. Immune tolerance mechanisms occur within the central lymphoid organs 
(thymus and bone marrow) during lymphocyte development, and continue in peripheral 




The critical ability of lymphocytes to differentiate between benign self-antigens and 
potentially pathogenic foreign antigens begins during their development within the 
thymus (T cells) and bone marrow (B cells). The basic premise of central immune 
tolerance, identification of lymphocytes that are capable of initiating an immune 
response (positive selection) and removal of those that vigorously respond to self-
antigens (negative selection), applies to both B cells and T cells. However, details of 
this process are better understood for T cell development (Takahama, 2006). As 
discussed above, bone marrow-derived T cell precursors begin development in the 
thymic cortex where they rapidly proliferate, progress through the four DN stages, 
rearrange the TCR genes, and finally co-express CD4 and CD8. Continued survival of 
these DP T cells relies on interactions between the recombined TCR and peptide/MHC 
complexes found on APCs within the thymus. Low affinity recognition of self-
peptide/MHC positively selects a developing T cell for survival, whereas lymphocytes 
with antigen receptors that fail to bind or demonstrate strong avidity for self-
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peptide/MHC are “neglected” or actively removed via apoptosis, respectively (Surh & 
Sprent, 1994). It is estimated that nearly 95% of thymocytes fail to progress beyond the 
cortical DP stage of development (Egerton, Scollay, & Shortman, 1990). Low-avidity 
interaction between the TCR of surviving T cells and peptide-MHC complexes promotes 
further differentiation, which includes up regulation of CCR7 ligands (Kwan & Killeen, 
2004), singular expression of either CD4 or CD8 (Campbell, Pan, & Butcher, 1999; 
Sohn, Forbush, Pan, & Perlmutter, 2001) and migration to the thymic medulla (Witt, 
Raychaudhuri, Schaefer, Chakraborty, & Robey, 2005). Within the medullary 
compartment, single positive (SP) thymocytes with a high affinity antigen receptor for 
self-peptide/MHC complexes are intentionally destroyed (negative selection) to prevent 
the release of mature self-reactive lymphocytes that could potentially initiate 
autoimmune disease.  
   
Autoimmune Regulator (AIRE) 
The breadth of self-antigen representation within the thymus for the purpose of negative 
selection and ultimately the removal of autoreactive T cells were considered to be 
limited to only ubiquitous antigens as recently as the late 1980’s. In addition, the 
identification of autoreative lymphocytes within the periphery (Guilbert, Dighiero, & 
Avrameas, 1982; Miller, Njenga, Parisi, & Rodriguez, 1996) resulted in the suggestion 
that peripheral, not central, immune tolerance had a larger role in preventing disease 
(Cohen, 1986). However, it is now recognized that the self-antigenic repertoire the 
thymus utilizes for central immune tolerance is extensive, representing nearly every 
peripheral organ and required to prevent the development of multiple autoimmune 
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disorders. This paradigm shift was initiated by three key observations. First was the 
detection of ectopic expression of transgenes driven by the insulin promoter within the 
thymus (Jolicoeur, Hanahan, & Smith, 1994). This observation resulted in the discovery 
of low levels of endogenous insulin expression within the thymus. Further investigation 
revealed that thymic insulin expression was important for preventing type-1 diabetes by 
eliminating insulin-specific T cells (Pugliese et al., 1997). Second was the development 
of multiple independent organ-specific autoimmune diseases following neonatal mouse 
thymectomy (Tong & Nelson, 1999). The removal of the thymus on the third day after 
birth results in disease by depleting the regulatory T cell population, which permits the 
unsuppressed activation of self antigen-specific T cells. Finally, the discovery of over 30 
peripheral organ specific antigens in purified pools of thymic stromal cells by qRT-PCR 
suggested that the repertoire of tissue-specific antigens used for deletional tolerance 
might be larger than previously imagined. The antigenic expression profile of the thymus 
has now been fully characterized, and includes several thousand genes, some of which 
are otherwise restricted to only a few peripheral tissues, including those that are 
differentially expressed in relation to age, sex and pubertal development (Anderson et 
al., 2002; Derbinski, Schulte, Kyewski, & Klein, 2001). These thymic proteins that are 
selectively expressed throughout an organism are known as tissue restricted antigens 
(TRAs).  
Thymic self-antigens are presented by resident APCs, cells that emigrate from 
circulation (B. A. Kyewski, Fathman, & Rouse, 1986), and the epithelial cells of the 
thymic cortex and medulla. However, an intrinsic property exclusive to the medullary 
thymic epithelial cells (mTECs), and to a lesser extent the cortical thymic epithelial cells 
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(cTECs), is the promiscuous gene expression (pGE) of tissue-restricted antigens that 
facilitates a comprehensive representation of antigenic self (Anderson et al., 2002; 
Derbinski et al., 2001). The mechanisms that result in mTEC pGE are still under 
investigation, however the study of this form of gene regulation has revealed five unique 
characteristics. First, promiscuous gene expression in the thymus occurs independent 
of the developmental parameters that controls their normal expression within a 
peripheral tissue. Second, expressed genes are commonly clustered within the 
genome. Third, different mTEC subsets preferentially express certain TRAs more 
frequently than others. Fourth, promiscuous gene expression mechanisms result in 
biallelic expression, even for those genes where one allele is normally silenced. Finally, 
single cell gene expression analysis has shown that each individual mTEC only express 
a few TRAs at one time and further that any overlap in expression of a given 
promiscuously expressed gene is limited to only 1-3% of mTECs (Derbinski, Pinto, 
Rosch, Hexel, & Kyewski, 2008).  
The autoimmune regulator (AIRE) protein is integral to the pGE of TRAs within the 
thymus. AIRE is a 545 amino acid transcriptional co-activator that is localized to 
chromosome 21q22 (Nagamine et al., 1997) and is mainly expressed within the nuclei 
of mTECs (Gray, Abramson, Benoist, & Mathis, 2007). Unlike classic DNA binding 
transcription factors, AIRE has the unique ability to influence the expression of several 
thousand genes (Johnnidis et al., 2005). Currently, its specific molecular mechanism of 
action remains unclear. However, its known binding partners (CBP, PIAS1, DNA-PK, 
and P-TEFb) (Abramson, Giraud, Benoist, & Mathis, 2010) as well as its unique 
combination of peptide domains (Anderson et al., 2005; Peterson, Org, & Rebane, 
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2008) that are found in other chromatin binding proteins and transcriptional regulators, 
has yielded some clues. Co-immunoprecipitation with molecules like CBP and DAXX 
suggests AIRE influences broad control over gene expression through association with 
higher order transcriptional complexes (Meloni et al., 2010; Pitkanen et al., 2005). 
However, AIRE has also been shown to selectively access genes within the casein 
locus (Derbinski et al., 2008), suggesting individual gene regulation in addition to 
influencing large genomic regions. Finally, AIRE implements epigenetic regulation of 
gene expression by increasing methylation at H3K4 as well as decreasing methylation 
at H3K27 (Koh et al., 2008; Org et al., 2008; Org et al., 2009). Precise molecular 
mechanisms aside, AIRE-induced gene expression provides a considerable proportion 
of the thymic self-antigen repertoire for the purpose of deletional tolerance.  
The full catalogue of AIRE-induced promiscuously expressed genes has been 
estimated at 3000, or roughly 5-10% of the genome (Gotter, Brors, Hergenhahn, & 
Kyewski, 2004). These genes provide extensive antigenic coverage and therefore 
significantly contribute to the tolerance of the various cell types and organ systems 
within the body. The combined discoveries of pGE and the AIRE protein have 
dramatically broadened the importance of central tolerance in stemming autoimmunity 
against not only common antigens but also to those that are rare or restricted in 
distribution. This shift in thinking has particular relevance to reproductive fitness. Many 
of the reproductive antigens expressed within the thymus are present simultaneously 
within their endogenous tissue distribution. However, some genes, including those for 
the casein family of proteins, HLA-G and AFP are only expressed following pubertal 
development and pregnancy (Derbinski et al., 2008; Lane et al., 2014; Mallet et al., 
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1999). The unique ability of AIRE to influence gene expression regardless of 
developmental status allows the immune system to become tolerized to antigens such 
as these prior to their normal expression in the periphery. The complete immunologic 
tolerance necessary for reproduction requires not only peripheral tolerance mechanisms 
(see below) including the partial sequestration of male germ cell antigens behind the 
blood-testis barrier (Yule, Montoya, Russell, Williams, & Tung, 1988) and lack of class I 
MHC expression on oocytes (Roberts, Taylor, Melling, Kingsland, & Johnson, 1992) but 
also likely dependent on centrally induced tolerance to a host of reproductive antigens. 
  
Peripheral Tolerance 
The thymic removal of autoreactive T cells is efficient, but not absolute. Peripheral 
immune tolerance is required for controlling the few high avidity and the more common 
low avidity self-reactive mature lymphocytes that escape negative selection (Liu et al., 
1995). Additionally, mechanisms of peripheral immune tolerance are responsible for 
specifically directing the activation of mature lymphocytes against foreign pathogens 
and containing the response once the infection has been cleared. Peripheral control 
begins with the requirement of multiple cooperative signaling events for complete B and 
T cell activation. The first signal, cross linking of multiple Ig receptors (B cells) or 
recognition of a complementary peptide/MHC complex (T cells), will only result in 
activation if it is accompanied by additional co-stimulatory signals. Engagement of CD40 
on B cells with CD154 on an antigen activated T cell is the principle co-stimulatory 
pathway leading to B cell activation, Ig affinity maturation and Ig class switching. 
Similarly, complete T cell activation requires binding of CD28 on T cells with the co-
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stimulatory molecules CD80/86 found on mature APCs (Fujii et al., 2004). Stimulation of 
the antigen receptor alone will render the lymphocyte unresponsive (Sloan-Lancaster, 
Evavold, & Allen, 1993) (anergic) and potentially initiate apoptotic pathways.  
The immune response is very powerful and if left unchecked could produce large 
collateral tissue damage or malignant cellular proliferation. Activated lymphocytes have 
intrinsic inhibitory mechanisms designed to protect the host from these detrimental 
outcomes once an infection has been cleared. Importantly, these mechanisms are 
initiated by signaling through the antigen receptor, but there is a delay in fulfillment of 
their inhibitory potential allowing time for the lymphocyte to perform its effector role. Key 
examples of inhibitory pathways include activation induced cell death and signaling 
through the programmed cell death-1 (PD-1) and cytotoxic T lymphocyte antigen 4 
(CTLA-4) receptors (Jones, Chin, Longo, & Kruisbeek, 1990; Nishimura, Nose, Hiai, 
Minato, & Honjo, 1999; Siegel & Fleisher, 1999; Waterhouse et al., 1995). Following 
activation, T cells will reduce expression of CD28 and induce the expression of CD95, 
CD120b, PD-1 and CTL-4. Signaling through CD95 and CD120b by Fas-ligand and 
TNF-α, respectively, induces apoptosis, whereas PD-1 and CTLA-4 are receptors that 
prevent signaling from the T cell receptor.  
Finally, Tregs provide a vital role in peripheral immune suppression by locally inhibiting 
several aspects of an immune response. Tregs are defined by an expression profile that 
includes CD4, CD25, CD127, CTLA-4 and the lineage-specific marker, Foxp3. They are 
activated in an antigen-specific manner, but inhibit nearby immune cells nonspecifically 
through the release of two potent anti-inflammatory cytokines, IL-10 and TGF-β. IL-10 
signaling results in the down-regulation of MHC class II and costimulatory molecules on 
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APCs, and blocks the secretion of proinflammatory cytokines, including IL-2, TNF-α and 
IFN-γ. TGF-β signaling through the SMAD pathway (Conery et al., 2004) induces 
apoptosis thereby directly preventing peripheral lymphocyte activation.  
 
IMMUNOLOGY OF REPRODUCTION 
Immune System and Normal Reproductive Physiology 
Female 
Ovary 
The ovaries are a pair of pelvic organs that produce gonadal steroids (estrogens and 
progesterone) as well as develop, store and release the female gamete. Briefly, 
primordial germ cells migrate to the gonadal ridge between the fourth and eight week of 
gestation. The absence of the SRY gene and Anti-Müllerian Hormone (AMH) allows for 
the establishment of the female gonad. The pool of oogonia expands mitotically through 
the first five months of gestation until a maximum allotment of approximately 5 to 7 
million germ cells is reached (T. G. Baker, 1963). At this point the oogonia initiate 
meiosis and arrest at prophase I, thereby becoming an oocyte. Next, cells from the 
neighboring mesothelium and mesonephros colonize the ovarian cortex. These 
infiltrating cells provide the supportive granulosa cells that encapsulate each oocyte, 
forming the primordial follicles, which remain quiescent until before puberty. The initial 
growth and expansion of follicles (folliculogenesis) from the primordial to the pre-antral 
stage occurs independently of gonadotropin signaling. At the onset of puberty, pulsatile 
secretions of FSH and LH promote the resumption of the meiotic cycle, follicular growth 
and the initiation of menstrual cyclicity (Messinis, 2006). Ultimately a single dominant 
	   47	  
follicle will be selected for ovulation from a small cohort of antral (2 – 5mm) follicles (D. 
T. Baird, 1987; Gougeon & Lefevre, 1983). The remaining subordinate follicles undergo 
a regressive process known as atresia that is likely apoptotic in nature (Tilly, Kowalski, 
Johnson, & Hsueh, 1991). Estrogen secreted from the dominant follicle prior to 
ovulation provides inhibitory feedback on GnRH secretion (Yamaji, Dierschke, 
Bhattacharya, & Knobil, 1972) and helps prepare the uterus for embryo implantation by 
stimulating uterine hyperplasia and inducing the upregulation of the progesterone 
receptor (van Dessel et al., 1996; Westergaard, Christensen, & McNatty, 1986). 
Following ovulation, the remaining theca and granulosa cells of the ovulatory follicle 
continue to grow, become vascularized and differentiate to form a corpus luteum(CL). 
The CL releases progesterone and to a lesser extent estrogen, which together ensure 
the receptivity of the uterus for the implantation of an embryo and maintains uterine 
quiescence during gestation. Although it should be mentioned that the role of luteal 
estrogen is not well understood and may not be necessary for pregnancy maintenance 
(Zegers-Hochschild & Altieri, 1995).  
The immune system has an important role in many ovarian functions, including 
ovulation, luteinization and luteal regression. Various leukocyte populations are 
recruited to the ovary throughout the menstrual cycle.  Both CD4+ and CD8+ T cells 
localize to the thecal layer of growing follicles and increase in density within atretic 
follicles and regressing CL (Suzuki et al., 1998). T cells are thought to play an important 
role in CL regression by activating macrophages and inhibiting steroidogenic pathways 
through the secretion of TNF-α and IFN-γ (Bagavandoss, Kunkel, Wiggins, & Keyes, 
1988; Komatsu, Manabe, Kiso, Shimabe, & Miyamoto, 2003). Mast cells are also 
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present within in the ovary and their densities vary through the estrous cycle (Gaytan, 
Aceitero, Bellido, Sanchez-Criado, & Aguilar, 1991). Histamine released by mast cells is 
thought to promote ovulation through the induction of progesterone production and the 
vasodilation of the ovarian vasculature (Kobayashi, Wright, Santulli, Kitai, & Wallach, 
1983). Macrophages and neutrophils are recruited to the ovary by the chemokines 
MCP-1 and IL-8, which are induced downstream of gonadotropin signaling (Arici et al., 
1997). Both of these cell types localize to the apex or stigma (region of ovarian surface 
through which the mature ovum will be released) of the dominant follicle (Takaya et al., 
1997) where they release matrix metalloproteinases. The breakdown of the extracellular 
matrix (ECM) by these secreted proteinases in combination with increase blood and 
intra-follicular pressure help to induce an ovulatory event. In addition, macrophages and 
neutrophils help promote neoangiogenesis within the developing CL after ovulation and 





The testis is the primary site of male androgen production and germ cell development. 
Structurally, the testis is an encapsulated series of highly coiled tubes (seminiferous 
tubules), inside of which sperm develop. Specialized epithelial cells called Sertoli cells, 
which are themselves surrounded by peritubular myoid cells, line the seminiferous 
tubules. The inter-tubular space is a loose connective tissue, which houses the 
testosterone-producing Leydig cells. Safeguarding this organ is essential for both male-
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specific development and fertility. There are numerous afflictions that can result in 
primary gonadal insufficiency (see above), including the careful regulation of the 
immune system within the testis to prevent autoimmune damage. The testis has long 
been considered an immune privilege site because of its ability to be successfully 
xenografted as well as accepting of xenografts (Honaramooz, Li, Penedo, Meyers, & 
Dobrinski, 2004; Selawry & Whittington, 1984). In general, immune regulation within the 
testis is considered suppressive, but not completely passive. This is important because 
immune components within the testis must still recognize and clear various infections 
(particularly bacterial) to prevent a permanent depletion of germ cells.  
The Sertoli cell, which establishes the germ-cell specific microenvironment necessary 
for proper mitotic and meiotic development of sperm, is also integral to immune 
regulation within the testis. A defining function of Sertoli cells to establish the blood-
testis-barrier (BTB), which is a unique series of basal tight junctions between the cells 
that isolates developing postmitotic spermatocytes from exposure to the immune 
system. In addition to the sequestration of sperm antigens, Steroli cells express TLRs 2-
7 and the apoptosis-inducing Fas Ligand as well as release various immune modulating 
factors such as the tryptophan metabolizing enzyme indoleamine 2,3-dioxygenase 
(IDO) and complement inhibitors (Fallarino et al., 2009; Lee, Richburg, Younkin, & 
Boekelheide, 1997; Wu et al., 2008). Leydig cells release TGF-β which, in addition to 
promoting Sertoli and germ cell proliferation induces the differentiation of 
immunosuppressive Tregs (Avallet, Vigier, Leduque, Dubois, & Saez, 1994; Boitani, 
Stefanini, Fragale, & Morena, 1995; Huber et al., 2009; Mather, Attie, Woodruff, Rice, & 
Phillips, 1990).  
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Finally, the leukocytes within the testis includes dendritic cells, macrophages and T cells 
(Itoh, De Rooij, Jansen, & Drexhage, 1995). Under normal physiologic conditions, these 
immune cells reside in the intertubular space and appear phenotypically shifted to 
promote immune tolerance. Tolerogenic dendritic cells are a special subset of DCs that 
are capable of enhancing the suppressive function of Tregs and rendering antigen-
specific T cells anergic (Aichele et al., 1994; Maldonado & von Andrian, 2010). Tregs 
and M2 macrophages both promote tolerance through the release of the immune 
suppressing cytokines TGF-β and IL-10 (Andersson et al., 2008; Bamboat et al., 2010). 
 
Epididymis  
The elongated spermotzoa that move from the testis to the epididymis are immobile and 
unable to fertilize an oocyte. The luminal environment of the epididymis provides the 
necessary signaling molecules that allow sperm to become progressively more motile 
and competent for capacitation, prior to being stored within the cauda. Structurally, the 
epididymis is, like the testis, a series of convoluted tubes; additionally, the epithelial 
lining is pseudostratified and the surrounding loose connective tissue contains abundant 
fibroblasts and smooth muscle.  
While the testis is considered immunologically privileged, the epididymis is not, and thus 
is also susceptible to infection. Important immune-related differences between the two 
sites include TLR expression, permeability of the epithelial tight junctions, frequency of 
leukocyte infiltration and the distribution of immune cells. Similar to Sertoli cells, the 
epithelial cells of the epididymis express TLR 2 – 7, but they also expression TLR 9 and 
11 (Palladino, Savarese, Chapman, Dughi, & Plaska, 2008). These cells also secrete 
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TGF-β and IL-10 (Bomgardner, Wehrenberg, & Rune, 1999). Compared to the BTB, the 
epithelial tight junctions of the epididymis are more permeable and have a classic apical 
location. Resident neutrophils are rare under normal conditions in the testis, but 
occasionally seen in the epididymis, and their density increases with age (Itoh, 
Miyamoto, Ohga, & Takeuchi, 1999). Finally, whereas the testis lacks leukocytes inside 
the BTB, the epididymal epithelium is replete with resident intraepithelial CD8+ T cells, 
macrophages, and dendritic cells (Da Silva et al., 2011; Serre & Robaire, 1999). 
Importantly, both of the antigen presenting macrophages and dendritic cells have been 
shown to extend dendrites towards the tight junctions of the blood-epididymal barrier 
(Da Silva et al., 2011). While the precise function of these intraepithelial APCs is not 
known, it has been suggested that they are either involved in maintenance of the 
mucosa (Geissmann, Gordon, Hume, Mowat, & Randolph, 2010) or are active 
participants in establishing immune tolerance to neoantigens present on post-testicular 
sperm (Da Silva et al., 2011).  
 
Autoimmune Disease and Infertility 
Susceptibility to autoimmune diseases involves a complex interplay between one’s 
genetics and their environment. The overall prevalence of autoimmunity in the general 
population is estimated at 3-5% (Jacobson, Gange, Rose, & Graham, 1997) and 
classically, is attributed to an aberrant response to a single self-antigen (Marrack, 
Kappler, & Kotzin, 2001). Many of those afflicted with autoimmune disorders are of 
reproductive age, and clinical studies over the past four decades have implicated an 
intrinsic association between fertility and autoimmunity. This relationship, even during 
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episodes of remission, can impact the gametes of both sexes, as well as all stages of 
gestation from fertilization through parturition. Further, maternal autoimmune disease 
can extend its influence into early neonatal and infant development. Based on these 
concerns, as little as 25 years ago women with a diagnosed autoimmunity were 
encouraged to refrain from having children. While recent advances in disease 
management have improved prognosis, pregnancies in women with a known 
autoimmune disorder are maintained as “high risk” due to the potential for complications 
(Gordon, 2004).  
Autoimmune disease can incite severe reproductive pathologies including premature 
ovarian insufficiency, infertility and recurrent pregnancy loss. In the general population 
there is a strong female gender bias in autoimmune disease presentation (Whitacre, 
2001). Diseases, including autoimmune thyroid disease, systemic lupus erythematous 
(SLE), Sjogren's and scleroderma maintain a patient population that is over 80% female 
(Beeson, 1994; Borchers, Naguwa, Keen, & Gershwin, 2010). While the cause of the 
sexual dimorphism is still being studied it is likely due impart to gender differences in the 
immune system and sex steroids (estrogen, progesterone and testosterone). Sex 
related immune differences include higher CD4 T cell populations, increased Th1 
cytokine produciton following vaccination and, in mice, incrase produciton of antibodies 
following immunization in females compared to males (Amadori et al., 1995; Eidinger & 
Garrett, 1972; Huygen & Palfliet, 1984). Evidence for hormonal influence on 
autoimmune disease includes estrogen-inhanced cytokine secretion in vitro, significantly 
reduced serum testosterone concentration in men with Rheumatoid arthritis (RA) and 
reduced disease severity for multiple sclerosis (MS) and RA during the third trimester of 
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pregnancy when estrogen and progesterone concentrations are at their peak (Birk et al., 
1990; Gilmore, Weiner, & Correale, 1997; J. L. Nelson & Ostensen, 1997; Ostensen & 
Villiger, 2007; Spector et al., 1989) 
 
Etiology and pathogenesis of autoantibodies 
Autoimmune disease is caused by an aberrant recognition and subsequent response of 
the adaptive immune system against self-tissue. A hallmark of these conditions is the 
presence of self-antigen specific antibodies. Although not always pathogenic, these 
autoantibodies can appear prior to the onset of disease symptoms (Heinlen et al., 2007; 
Nielen et al., 2004) and are representative of the antigen driving the immune response, 
making them both predictive and diagnostic (ter Borg, Horst, Hummel, Limburg, & 
Kallenberg, 1990; Vencovsky et al., 2003). Determining both the originating antigenic 
stimuli and if the disease is mediated through a cellular or humoral mechanism has 
important research and clinical value. However, as disease etiologies have remained 
elusive for several autoimmune disorders, a complete understanding of the progression 
may facilitate effective management strategies without a definitive knowledge of the 
origin.  
Direct evidence for humoral pathogenicity requires serum transfer followed by the 
development of disease symptoms in the recipient. While there are a few examples of 
passive disease transfer using human autoantibody-containing serum into immune-
deficient mice (Anhalt, Labib, Voorhees, Beals, & Diaz, 1982; Robinson et al., 1998; 
Wooley et al., 1984), perhaps the best evidence for human autoantibody pathogenicity 
comes from transplacental transfer of autoantibodies during pregnancy leading to 
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neonatal disease. Maternal-fetal transfer of pathogenic antibodies has been 
demonstrated for range of autoimmune conditions including Graves’ disease, 
myasthenia gravis, neonatal lupus and the antiphospholipid syndrome (G. M. Fenichel, 
1978; Mahoney, Pyne, Stamm, & Bakke, 1964; Motta et al., 2012; Vonderheid, 
Koblenzer, Ming, & Burgoon, 1976). Excluding a few serious examples like congenital 
heart block and extensive thrombosis, the disease symptoms generally wane quickly 
after birth as the exogenous antibodies are cleared (Appan, Boey, & Lim, 1987; Buyon 
et al., 1998).  
Indirect evidence for pathogenic antibody involvement in autoimmune disease derives 
from serum transfer experiments in a variety of animal model systems that reflect 
human diseases. Examples include collagen-induced autoimmune arthritis (Stuart & 
Dixon, 1983), anti-myosin antibodies in autoimmune myocarditis (Liao et al., 1995) and 
anti-cardiac troponin I antibodies from Program Death-1 (PD-1) KO mice resulting in 
cardiomyopathy (Okazaki et al., 2003). Other prominent autoimmune animal model 
systems include the multiple sclerosis-like demyelination in the Experimental 
Autoimmune Encephalomyelitis (EAE) mice (Bernard & Carnegie, 1975), multi-organ 
autoimmune disease in AIRE-deficient mice (Anderson et al., 2002) and the Type-I 
Diabetes-like syndrome in non-obese diabetic (NOD) mice (Makino, Muraoka, 
Kishimoto, & Hayashi, 1985). However in each of these models the disease symptoms 
are passaged through cellular transfer, not serum, indicating that the autoantibodies, 
despite the presence of high titers, are not pathogenic (Bernard, Leydon, & Mackay, 
1976; Gavanescu, Benoist, & Mathis, 2008; Wicker, Miller, & Mullen, 1986).  
The precise mechanisms by which autoantibodies produce tissue damage and 
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inflammation vary by disease. The production self-reactive, high affinity, non-IgM 
antibodies typically requires assistance from the Th2 subset of CD4+ T cells (Allen, 
Okada, & Cyster, 2007; Shih, Meffre, Roederer, & Nussenzweig, 2002). Once in 
circulation autoantibodies can facilitate tissue damage through numerous pathways. 
Autoantibody ligation of a receptor can either neutralize or inappropriately active the 
signaling pathway. Similar to the normal function of antibodies, autoantibodies can 
opsonize their target resulting in the detection and destruction of normal tissues by 
innate immune cells. Finally, deposition of immune complexes (antibody plus soluble 
antigen) within various tissues can activate many inflammatory pathways resulting in 
tissue damage (D. Sylvestre et al., 1996; D. L. Sylvestre & Ravetch, 1994).  
 
Ovarian Autoimmune Disease 
Primary Ovarian Insufficiency (POI), previously termed premature ovarian failure or 
premature menopause, is defined by an elevation in pituitary gonadotropins, 
hypogonadism and amenorrhea in women with a normal karyotype before the age of 
40. The overall incidence of POI is 1 in 100 and of this, approximately 4% is caused by 
an autoimmune oophoritis (Bakalov et al., 2005; Bannatyne, Russell, & Shearman, 
1990; Sedmak, Hart, & Tubbs, 1987). The existence of isolated autoimmune POI is 
under debate as the disease is virtually always associated with other autoimmune 
disorders, most predominantly autoimmune adrenal disease (Bannatyne et al., 1990; 
Betterle et al., 1997; Sedmak et al., 1987). Association with other autoimmune diseases 
can include thyroid disease, myasthenia gravis and APS Type I and II (Betterle, Dal Pra, 
Mantero, & Zanchetta, 2002; Forges, Monnier-Barbarino, Faure, & Bene, 2004; Kim et 
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al., 1997; Ryan & Jones, 2004). 
Autoimmune POI is uniquely distinguished by the presence of enlarged cystic ovaries in 
approximately half of all cases, thecal cell destruction in the absence of granulosa cell 
involvement, normal to elevated levels of inhibin B and the detection of anti-steroid cell 
antibodies (S. Chen et al., 1996; Falorni et al., 2002; Lonsdale, Roberts, & Trowell, 
1991; Welt, Falorni, Taylor, Martin, & Hall, 2005). Indirect immunoflorescence detection 
of anti-21-hydroxylase antibodies (Bakalov et al., 2005) is the standard diagnostic 
marker; however, additional anti-steroid cell antibodies are also found. In the rare cases 
of autoimmune POI without adrenal disease, patients lack steroid-cell autoantibodies, 
but instead may possess anti-thyroid or anti- acetylcholine receptor autoantibodies 
(Bakalov et al., 2005; Dal Pra et al., 2003; Falsetti, Scalchi, Villani, & Bugari, 1999; Luo, 
Garza, Hunt, & Tung, 1993).  
Pathogenesis of autoimmune POI remains under investigation (L. M. Nelson, 2009). 
The two predominant theories include an initial viral infection leading to molecular 
mimicry (Garza & Tung, 1995) and/or failed immune tolerance. Histologic evaluations of 
ovarian biopsies from women with POI have shown lymphocyte infiltration into the theca 
layer of growing follicles, as well as luteal tissue (L. M. Nelson et al., 1994). Consistent 
with an immune etiology of autoimmune POI, the absence of primordial cell destruction 
combined with case reports of menstrual cycle resumption with administration of 
glucocorticoids (Rabinowe, Berger, Welch, & Dluhy, 1986) suggests a possible window 
for fertility preservation if autoimmune POI is diagnosed early. Importantly, IVF protocols 
have been developed that use a combination of hormonal therapy, oocyte donation and 
intra-cytoplasmic sperm injection (ICSI) to facilitate a successful pregnancy in women 
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with POI (Lutjen et al., 1984).  
 
Autoimmune models of ovarian disease 
The principle model of autoimmune oophoritis is derived from the removal of the thymus 
three days after birth (D3TX). The consequence is a depletion of regulatory T cells 
which allows the development of spontaneous ovarian autoimmunity in over 95% of 
female mice (Tung, Smith, Teuscher, Cook, & Anderson, 1987). The disease, which 
develops 4 to 6 weeks following surgery, results from activation of naïve ovarian 
antigen-specific effector T cells and can be prevented by the adoptive transfer of 
polyclonal Tregs shortly following thymectomy (Asano, Toda, Sakaguchi, & Sakaguchi, 
1996). Additionally, simultaneous thymectomy and oophorectomy deprives effector T 
cells of antigenic stimuli and as a result prevents development of disease (Alard et al., 
2001). Several key conclusions about ovarian autoimmune disease have been derived 
from the use of this model. First, the disease is cellular in nature and passaged by 
CD4+ T cells, not CD8 T cell or antibodies. Second, disease prevention is facilitated by 
antigen-specific Tregs that require prior exposure to endogenous ovarian antigens. 
Third, the immune suppressive function of these specific Tregs occurs specifically in the 
lymph nodes that drain the ovary (Samy, Parker, Sharp, & Tung, 2005). Finally, the 
Maternal Antigen That Embryos Requires (MATER) has been identified as the ovarian 
specific protein responsible for oophoritis in the D3TX model (Taguchi, Nishizuka, 
Sakakura, & Kojima, 1980). Development of anti-MATER antibodies corresponds with 
initial ovarian lymphocyte infiltration suggesting that in this model, MATER is the 
primary immune target when immune regulation has been disrupted. 
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Orchitis 
Systemic infections are known to impinge on reproductive success. In the male, the 
most common outcome is a suppression of the hypothalamic-pituitary-gonadal (HPG) 
axis, which results in reduced androgen production due to a failure in LH stimulation of 
Leydig cells (Kalyani, Gavini, & Dobs, 2007). Under normal physiologic conditions, 
intratesticular testosterone is purposely elevated through an association with androgen 
binding protein and its signaling is required for Sertoli cell function and spermatogenic 
support. In addition, Steroli cells express a battery of TLRs (see above) and cytokine 
receptors that can respond to inflammatory signals. Unfortunately, the exact mechanism 
of inflammation related male infertility is unknown. One possibility is that reduced 
androgen levels coupled with inflammatory signaling pathways is impairing 
spermatogenesis through a disrupt BTB integrity (Koksal et al., 2007). A second 
possibility is that inflammatory signaling through the seminiferous epithelium is 
disrupting normal Sertoli cell-germ cell interactions. Bacterial lipopolysaccharide 
induced changes within the seminiferous tubules include apoptosis of spermatocytes, 
loss of germ cell – Sertoli cell contact and vacuolization of spermatid nuclei (O'Bryan, 
Schlatt, Phillips, de Kretser, & Hedger, 2000).  
Direct testicular inflammation generally results from a disseminating epididymal infection 
and has the same pathogenic origin. Isolated orchitis is less common than orchido-
epididymitis (Kaver, Matzkin, & Braf, 1990) and is usually viral in origin (Masarani, 
Wazait, & Dinneen, 2006). Non-infectious orchitis can result from physical trauma, 
cancer, vasectomy or autoimmune disease.  
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Epididymitis 
Inflammation of the epididymis is the most common intrascrotal infection (Luzzi & 
O'Brien, 2001) affecting approximant 600,000 males between the ages of 18 and 35 
each year (Krieger, 1984). Epididymitis is classified as either acute or chronic and 
typically results from an ascending bacterial infection of either N. gonorrhoease or C. 
Trachomatis (Redfern, English, Baumber, & McGhie, 1984), although several other 
infectious agents can cause epididymal inflammation. Similar to non-infectious orchitis, 
epididymitis can also result from physical trauma, cancer, vasectomy or autoimmune 
disease. While epididymitis can occur in isolation, it usually spreads to the testis, where 
the infection can impair spermatogenesis and steroidogenesis. Consequently the 
epididymis is affected directly by local inflammation and indirectly by a loss of androgen 
signaling.  
 
Autoimmune models of testicular and epididymal disease 
The experimental evidence for an autoimmune component to orchiepididymitis is 
derived from studies with Aire-KO mice, day 3 neonatal thymectomy (D3TX) and 
experimental models of autoimmune orchitis (EAO). A deficiency in AIRE in both 
humans and mice can result in male infertility. A study of the autoimmune components 
leading to male infertility is a principle focus of this dissertation and will be discussion in 
detail below.  
The removal of the thymus at neonatal day 3 causes a multi-organ autoimmunity due to 
a disruption of peripheral T-reg-mediated tolerance (see above). Two of the specific 
targets of this model are the testis and the epididymis. Within the testis autoantibodies 
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are deposited on the surface of sperm as well as the nuclei of Sertoli cells (Tung et al., 
1987). In the epididymis, male mice generate autoantibodies against the nuclei and 
luminal surface of the tubule epithelium as well as those against the surface of the 
sperm and the acrosome (Taguchi, Kojima, & Nishizuka, 1985; Tung et al., 1987). 
Approximately 30% of male D3TX mice will spontaneously develop orchitis. This is in 
contrast to the prevalence of oophoritis in female D3TX and is likely due to the local 
immune-modulatory environment of the testis compared to the ovary (Tung & Teuscher, 
1995). Two key points have been derived from the study of male reproductive tract 
autoimmune disease using the D3TX model. First, the percentage of mice with orchitis 
increases to over 90% following vasectomy. Vasectomy is thought to result in the 
release of immune stimulatory sperm antigens. A similar response in witnessed in 
humans, where following vasectomy the prevalence of anti-sperm antibodies increases 
(Ansbacher, 1973). However, the pathogenicity of anti-sperm antibodies following 
vasectomy appears to be dependent on the presence or absence of T regulatory cells 
(Wheeler et al., 2011). Second, the presence of epididymitis always precedes orchitis in 
the D3TX model system (Taguchi & Nishizuka, 1981). This observation suggests that 
the inciting antigen in the D3TX model is present on mature sperm within the epididymis 
and the later testicular involvement is either through epitope spreading or a non-specific 
dissemination of the original inflammation (Vanderlugt et al., 1998). 
A third model of autoimmune recognition of the male reproductive tract, known as 
Experimental Autoimmune Orchitis (EAO), is the result of artificial immunization with 
male reproductive tissue extracts. EAO is induced by injecting male reproductive tract 
antigens, with or without adjuvant, into the footpad. The majority of the initial studies 
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were preformed using guinea pigs as a model (Freund, Lipton, & Thompson, 1953). 
Induction of EAO in the mouse proved to be more difficult, requiring addition of 
particular extracts, repeated antigen injection or very strong adjuvants (Kohno et al., 
1983; Sakamoto, Himeno, Sanui, Yoshida, & Nomoto, 1985; Sato, Hirokawa, & 
Hatakeyama, 1981). A possible explanation for the differences in these model systems 
is relative permeability of the blood-testis-barrier. The BTB in the guinea is more 
permeable to macromolecule and as a result exposure of sperm antigens to the immune 
system as well as passage of antisperm antibodies into the seminiferous tubules is 
likely increased (M. H. Johnson, 1970; Moroi et al., 1998). Similarly, increase 
susceptibility to orchitis in the mouse with the addition of Bordetella pertussis extract is 
likely due to a disruption of the BTB (Adekunle, Hickey, Smith, Tung, & Teuscher, 1987; 
Amiel, 1976; Bruckener, el Baya, Galla, & Schmidt, 2003). Additionally, the ability of 
repeated inoculation with male reproductive tract antigens to drive a testicular immune 
response, even without adjuvant, suggests the requirement of a memory response to 
induce EAO (Itoh, Hiramine, & Hojo, 1991). Finally, one important contradiction between 
the EAO and the D3TX model of autoimmune orchitiis is that the EAO protocols can be 
adjusted to allow for isolated epididymitis, orchid-epididymitis or isolated orchitis. For 
example, injection of testicular sperm extract without an adjuvant results in orchitis 
without a corresponding response against the epididymis  (Itoh et al., 1991) and 
immunization with whole epididymal lysate or testiscular spermatids both with an 
adjuvant causes induction of epididymis (Itoh et al., 1992; Tung et al., 1987). These 
findings suggest that there are multiple male reproductive tract antigens capable of 
provoking autoimmunity and that the likelihood of their development can be influenced 
	   62	  
by other ongoing immune activity.  
 
Autoimmune Polyglandular Syndrome Type I (APS-I)  
Epidemiology 
The AIRE gene is a component of central immune tolerance whose function is to 
prevent autoimmune disease by removing developing lymphocytes with a high-affinity 
antigen receptor for self-peptides. Functionally disruptive mutations of this gene, of 
which over sixty have been documented (Heino et al., 2001; Mathis & Benoist, 2007), 
results in a multi-organ autoimmune disease known as Autoimmune Polyendocrine 
Syndrome Type-I (APS-1). APS-1 is a rare autosomal recessive (Nagamine et al., 1997) 
disorder that was first described in 1946 (Leonard, 1946). However, in some isolated 
populations the frequency of APS-1 can increase to 1:9000 for Iranian Jews, 1:14,000 
for Sardinians and 1:25,000 for Finns (Bjorses et al., 1996).  
 
Pathophysiology 
APS-1 patients suffer from a multi-organ autoimmune disorder characterized by a high 
degree of target variability, CD4+ T cell infiltrates and the generation of autoantibodies 
against afflicted organs (Anderson et al., 2002; Ramsey et al., 2002; Vogel, Strassburg, 
Obermayer-Straub, Brabant, & Manns, 2002). The pathogenesis is clearly genetic, 
however there are environmental inputs that contribute to the variability of autoimmune 
targets. The best example of this comes from identical siblings with matching genetic 
disruptions in the AIRE gene that have a different constellation of symptoms (De Luca 
et al., 2008). Serum autoantibodies can be suggestive of autoimmune targets and may 
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exacerbate the severity, but are likely not the inciting factor. B cell deletion studies in 
Aire-deficient mice show reduced disease severity, particularly for chronic 
mucocutaneous candidiasis (Gavanescu et al., 2008). Alleviation of chronic 
mucocutaneous candidiasis in this model is likely due to an elimination of 
autoantibodies specific for two important cytokines in musical immunity, IL-17 and IL-22 
(Kisand et al., 2010; Puel et al., 2010). However, serum transfer alone of autoantibodies 




The high degree of disease variability and timing of onset can make APS-1 difficult to 
identify and treat. A definitive diagnosis requires two of the three following symptoms; 1) 
Addison’s disease, 2) hypoparathyroidism and 3) chronic mucocutaneous candidiasis 
(Betterle, Greggio, & Volpato, 1998). In humans, candida (yeast) infections are the most 
common symptom at presentation, affecting over 60% of patients and eventually 
present in all by the age of 40. Hypoparathyroidism is the most common endocrine 
dysfunction. It has a higher frequency in women compared to men and impacts more 
than 30% at presentation, eventually manifesting in over 80% of all APS-1 patients. 
Finally Addison’s disease (adrenal insufficiency) is the third most common symptom 
appearing in approximately 60% of patients by the age of 15. In addition, a variable 
percentage of afflicted patients present with secondary autoimmune ailments, including 
thyroiditis (5%), ovarian insufficiency (60%), hepatitis (12%) and type 1 diabetes (T1D) 
(14%) (Kogawa et al., 2002; Podkrajsek et al., 2008). Two final complicating factors 
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include age of onset, which can range from two month to 18 years, and atypical 
symptoms. Unusual presentation is more common in young patients and involves are 
variety of symptoms including dry eye, hyperkalemia, nephritis and rash (Perheentupa, 
2006).  
 
Murine Models of Aire Deficiency 
Similar to APS-1 patients, ablation of the Aire gene in mice produces a multi-organ 
autoimmune syndrome complete with autoantibodies and CD4+ infiltrates (Jiang, 
Anderson, Bronson, Mathis, & Benoist, 2005; Kuroda et al., 2005). Analysis of several 
murine models on different genetic backgrounds has revealed that the pathogenesis of 
APS-1 is due to a loss in the expression of the majority of Aire-regulated antigens within 
mTECs, culminating in the escape of autoreactive T cells (Anderson et al., 2002). 
Consistent with this view, several authors have established a correlation between the 
thymic loss of TRAs and the autoimmunity that ensues, including MUC6 for gastritis, 
MATER for ovarian insufficiency, INS2 for T1D and IRBP for uveitis (Alimohammadi et 
al., 2008; Anderson et al., 2002; J. DeVoss et al., 2006; Gavanescu, Kessler, Ploegh, 
Benoist, & Mathis, 2007; Sabater et al., 2005). Disease severity and commonality of 
autoimmune targets are significantly influenced by strain differences. Aire-KO mice 
developed on the B6 background (Hubert et al., 2009) have a mild, almost autoimmune 
protected phenotype, whereas those on the non-obese diabetic (NOD) background 
have a very severe disease presentation including exocrine pancreatitis, gastritis and 
early morbidity (Niki et al., 2006). Aire-deficient mice on the Balb/c genetic background 
(Jiang et al., 2005) have an intermediate phenotype that includes dry eye, gastritis, 
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gonadal insufficiency (Jasti et al., 2012) and longevity of at least a year. Finally, some 
groups have utilized a B6/NOD hybrid background to precipitate and study certain 
autoimmune diseases, including chronic prostatitis (Hou et al., 2009), without elevated 
mortality rates.  
 
Our understanding of pregnancy complications secondary to autoimmune disease is 
incomplete. Additionally, even less is known about the contributions of central immune 
tolerance on fertility. The discovery of the AIRE as the gene responsible for the disease 
known as the Autoimmune Polyendocrine Syndrome-I has provided new insights into 
the mechanisms of central immune tolerance. AIRE-induced gene expression within the 
thymus provides a pool of self-antigens used for the removal of developing autoreactive 
T cells. A disruption of this gene causes incomplete central immune tolerance and 
results in a multi-organ autoimmune disorder. Many of the proteins regulated by AIRE 
are co-expressed within the male and female reproductive tracts. In the following 
dissertation, I will use an Aire-deficient mouse model to explore the hypothesis that 
AIRE-mediated central tolerance to various reproductive tract antigens is required for 
male and female fertility preservation. Further, I will attempt to identify the specific 
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ABSTRACT 
 
The Autoimmune Regulator (AIRE) is responsible for establishing central immune 
tolerance through the induction of self-antigen expression within the thymus. A defect in 
the AIRE gene results in a multi-organ autoimmune disorder known as Autoimmune 
Polyglandular Syndrome Type-1. Humans, as well as mice, with a deficiency in this 
gene produce autoreactive CD4+ T cells, increased concentrations of serum 
autoantibodies and present with elevated rates of infertility. Ovarian autoimmunity 
causing a depletion of follicular reserves is prominent in female Aire-deficient (KO) mice 
over 10 weeks of age. However, 50% of mated six-week old female Aire-KO mice 
demonstrate embryonic loss by embryonic day (ED) 7.5 despite having normal follicular 
reserves. We determined that ovulation (90% KO vs 100% WT; n=11), ability to mate 
(99% KO vs 100% WT; n= 71 and 58 respectively), serum progesterone production at 
ED5.5 (P=0.232; n=4) and the decidual response are unaffected by Aire deficiency. 
Additionally, Aire-KO females did not generate unique serum autoantibodies against the 
uterus, placenta or embryo. However, 60% (9 of 15) of 6-8 week old Aire-KO female 
mice generated autoantibodies against the ovary, and ovulated an increased 
percentage of degenerated oocytes (31% KO vs 2% WT; n=74 and 71 respectively). 
When cultured, one-cell stage embryos from Aire-KO females progressed to the 2-cell 
and blastocyst stage of development at significantly reduced rates compared to WT 
controls (47% KO vs 76% WT and 19% KO vs 60% WT; n=74 KO, n=67 WT). Finally, 
embryos from Aire-KO dams are developmentally delayed at ED3.5 and displayed a 
reduced trophectoderm outgrowth potential after 48 and 96 hours of culture (median 
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values: 0mm2 KO vs 6.8 mm2 WT, and 7.6 mm2 KO vs 30.2 mm2 WT; P<0.001, n=4). 
Collectively these results suggest that ovarian autoimmune disease due to a 
dysfunction in central immune tolerance can impact the health and quality of female 







































	   69	  
INTRODUCTION 
 
Infertility or subfertility are unfortunately common conditions with profound social, 
economic, medical and psychological implications, and are estimated to impact between 
6 and 25% of couples world-wide (Boivin et al., 2007; Chandra A, 2013; Greenhall & 
Vessey, 1990). While the cause of compromised fertility can originate with either partner 
or as a combination of both, it is suggested that a female factors cause approximately 
55% of infertility cases (Forti & Krausz, 1998; Hull et al., 1985; Mahmoud, 2000). 
Among the potential causes of female-factor infertility are a wide range of autoimmune 
disorders including autoimmune-primary ovarian failure, autoimmune-thyroiditis, 
autoimmune-Addison’s disease. These conditions are associated with generation of 
autoantibodies against sperm, the ovary, phospholipids, steroidogenesis enzymes and 
nuclear antigens (Abalovich et al., 2007; Blumenfeld et al., 1993; S. Chen et al., 1996; 
Empson, Lassere, Craig, & Scott, 2002; Falorni et al., 2002; Hoek, Schoemaker, & 
Drexhage, 1997; Mathur et al., 1981; Motta et al., 2012; Oshiro, Silver, Scott, Yu, & 
Branch, 1996; Shatavi, Llanes, & Luborsky, 2006; Winqvist et al., 1995; Xu et al., 1990). 
Importantly, the prevalence of autoimmunity is higher in females and with a predilection 
to manifest during the reproductive years.  
 
The regulation of the immune system, which is responsible for the identification and 
removal foreign pathogens while remaining tolerant to self-antigens, is essential for 
reproductive viability. The integration of female fertility and the immune system is very 
complex and requires a high degree of pliability. The female immune system must 
simultaneously maintain tolerance to the reproductive tract, avoid systemic inflammation 
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and remain ignorant or tolerant to a host of neo-antigens present within sperm, the 
placenta and the semi-allogeneic fetus (Moffett & Loke, 2006; Stimson, Strachan, & 
Shepherd, 1979; Suri, 2004; Taglauer, Adams Waldorf, & Petroff, 2010). However, the 
immune system cannot simply shut down since susceptibility to infection would increase 
and several key reproductive events, including ovulation, implantation and remodeling 
of the uterine spiral arteries require immunological involvement (Aluvihare, Kallikourdis, 
& Betz, 2004; M. K. Collins, Tay, & Erlebacher, 2009; Loke & King, 2000; Moffett & 
Loke, 2006).  
 
Autoimmune disease is caused by the loss of immunologic self-tolerance resulting in an 
inflammatory response against self-antigens. These conditions and an individual’s 
susceptibility have proven difficult to study as they often involve both host genetics and 
environmental factors (Marrack et al., 2001). Rare cases of monogeneic disorders 
leading to autoimmunity, as exemplified by polymorphisms in the gene encoding the 
autoimmune regulator (AIRE), can provide novel insight into the mechanisms behind 
these diseases (Akirav, Ruddle, & Herold, 2011; B. Kyewski & Derbinski, 2004). 
Autoimmune polyglandular syndrome type 1 (APS-1) (Ahonen, 1985), the disease 
resulting from a deficiency in AIRE, is a multi-organ autoimmune disorder that produces 
autoreactive T cells and high serum titers of autoantibodies (Soderbergh et al., 2004). 
Clinically, patients present with two of the following three pathologies: adrenal 
insufficiency, chronic mucocutaneous candidiasis and hypoparathyroidism (Ahonen, 
Myllarniemi, Sipila, & Perheentupa, 1990; Bjorses et al., 1996). Additionally, patients 
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often develop a broad range of secondary autoimmune-mediated complications, 
including elevated rate gonadal insufficiency (Ahonen et al., 1990). 
 
The AIRE gene encodes a 58-kDa protein that is predominately expressed by thymic 
medullary epithelial cells (Bjorses et al., 1996; Heino et al., 2001) and possesses 
structural and functional attributes suggestive of a transcription factor (Anderson et al., 
2002; Nagamine et al., 1997). While the exact mechanism remains unclear, AIRE, 
through its molecular motifs (Nagamine et al., 1997) and various binding partners 
(Abramson et al., 2010), has a vital role in establishing central immune tolerance by 
regulating the “promiscuous” expression and presentation (Kuroda et al., 2005) of 
numerous tissue-specific self antigens (Anderson et al., 2002; Derbinski et al., 2005; 
Derbinski et al., 2001). Importantly, developing autoreactive T cells are removed 
following exposure to these self-antigens (Anderson et al., 2005; Liston, Lesage, 
Wilson, Peltonen, & Goodnow, 2003), some of which are also found within, and even 
restricted in their non-thymic tissue distribution to the ovary, placenta and embryo 
(Derbinski et al., 2005).  
 
Disruption of the murine Aire gene, which is 71% homologous with the human correlate 
(Halonen et al., 2001), effectively models many of the key attributes of APS-1. Aire-
deficient mice fail to express many tissue restricted antigens within the thymus, 
(Anderson et al., 2002; Derbinski et al., 2005), which causes inappropriate escape of 
self-reactive T cells and culminates in development of autoreactive CD4+ T cell and 
antibodies (Anderson et al., 2002; Hubert et al., 2009; Kuroda et al., 2005; Ramsey et 
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al., 2002). In addition, disease onset and severity is highly variable both within and 
between genetic backgrounds (Jiang et al., 2005). Interestingly, several reports 
speculate that decreased fertility in homozygous Aire-deficient mice breeding pairs is 
due to a male specific factor (Anderson et al., 2002; Hubert et al., 2009; Kuroda et al., 
2005; Ramsey et al., 2002). However, we have previously shown 50% infertility in 
female Aire-deficient mice due to premature ovarian follicular senescence (Jasti et al., 
2012). In the present study we explore the consequences of a disruption of AIRE-
mediated gene expression on fertility in six-week old female Balb/c Aire-deficient mice 
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METHODS AND MATERIALS 
 
Animals 
Aire-deficient (KO) mice on the Balb/cJ genetic background (>8 generations) (Anderson 
et al., 2002; Jiang et al., 2005) were a generous donation to our laboratory by C. 
Benoist and D. Mathis (Harvard Medical School, Boston, MA). Mice were housed under 
pathogen-free condition at the University of Kansas Medical Center (KUMC); all 
experiments both complied with NIH Guidelines for the Care and Use of Laboratory 
Animals and were approved by the Institutional Animal Care and Use Committee at 
KUMC. The Aire-KO female mice used in these experiments were generated using 
heterozygous breeders. Wild type (WT) Balb/cJ males and females were obtained from 
The Jackson Laboratory (Bar Harbor, ME, USA). Genotypes were confirmed by a single 
PCR reaction using the following primer set: FWD 5’ GTCCCTGAGGACAAGTTCCA 3’; 
REV 5’ GGGACTGGTTTAGGTCCACA 3’. WT mice generate a 758 bp product, Aire-
KO mice yield a 297 bp product and heterozygous animals produce both.  
 
Blood and Tissue collection 
Wild type and Aire-deficient females were sacrificed for the collection of blood, ovaries, 
implantation sites and the recovery of transplanted ovaries. Mice were anesthetized with 
a sterile solution of 2,2,2-Tribromoethanol (250mg/kg IP, Sigma-Aldrich, St. Louis, MO) 
dissolved in 2-methyl-2-butanol (Sigma-Aldrich, St. Louis, MO). Serum was collected 
under anesthesia via cardiac puncture and stored at -20°C. Mice were then euthanized 
via cervical dislocation and opening of the cardiac cavity, after which the tissues were 
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removed, fixed in 4% paraformaldehyde (PFA) overnight, dehydrated in 70% ethanol, 
embedded in paraffin and stored at 4°C.  
 
Fertility assessment and weight monitoring 
Fertility was evaluated in 6-week-old WT controls and Aire-KO females at embryonic 
day 5.5, 7.5 and 10.5 (n ≥ 13 for each genotype at each collection point). Females were 
cohabited with a single Balb/c WT male and checked daily for the presence of a 
copulatory plug. The duration to initial mating was recorded, and following mating their 
body weight was measured daily between 9 and 10 am until sacrifice at embryonic day 
5.5, 7.5 or 10.5. Fertility was assessed by the presence of implantation sites at the time 
of sacrifice.  
 
Embryonic day 0.5 embryo collection and in vitro culture 
To assess the in vitro development of 0.5-day embryos, six-week old WT (n=11) and 
Aire-KO (n=10) females were cohabitated with a single Balb/c male mouse and 
evaluated daily for presence of a copulatory plug. The afternoon following a mating 
event, mice were anesthetized as above, and the oviducts were isolated by dissection. 
Oocytes were flushed from the oviducts using FHM-Hepes (EMD Millipore, Billerica, 
MA) and incubated in 0.3mg/ml hyaluronidase (Sigma-Aldrich, St. Louis, MO) for 10 
minutes to remove cumulus cells. Oocytes were counted and evaluated for health 
(Nagy, Gertsenstein, Vintersten, Behringer, & Gersenstein, 2002) before being washed 
through and stored in microdrops of KSOM with amino acids and D-Glucose (EMD 
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Millipore, Billerica, MA). Embryos were visualized on an inverted light microscope 24 
and 96 hours post fertilization and the numbers and stages of embryos recorded.  
 
Determination of serum progesterone levels  
To determine progesterone levels in mated wild type and Aire-KO females sacrificed at 
embryonic day 5.5, 7.5 and 10.5, serum progesterone was measured by 
radioimmunoassay at the University of Virginia Center for Research in Reproduction 
Ligand Assay and Analysis Core (Charlottesville, VA). The sensitivity of the assay is 0.1 
ng/mL with a range of 0.1-40 ng/mL. 
 
Immunoblotting 
Presence of serum autoantibodies in WT and Aire-KO mice against components of the 
reproductive tract and fetal-placental unit was determined by immunoblot analysis using 
lysates from Rag2-deficient mice (C.129S6(B6)-Rag2 tm1Fwa, Taconic). The tissue was 
homogenized on ice in RIPA buffer and then boiled for five minutes in a buffer 
containing 10% glycerol, 40mM Tris (pH 6.8), 1% SDS, 10% 2-mercaptoethanol and 
0.01% bromophenol blue. 400µg of lysate was run on a 4-20% TGX stain-free curtain 
gel (BioRad, cat# 567-8091, Hercules, CA) and transferred to a Whatman Protran 
nitrocellulose membrane (GE Healthcare Life Sciences) at 100 V for 20 minutes. The 
membrane was blocked for 3 hours at room temperature with a 3.5% solution of BSA 
(Sigma-Aldrich) in PBS (pH 7.4) before being placed inside a Mini-Protean II 
Multiscreen apparatus (BioRad). Sera (1:750 dilution) from WT (n=5) and Aire-KO 
(n=15) mice were loaded into the slots and incubated at 4°C for 18 hours. The 
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membrane was washed several times with PBS containing 0.1% Tween 20 and then 
incubated with an HRP conjugated anti-mouse secondary antibody (Sigma-Aldrich). 
Immunoreactivity was visualized with an ECL detection kit (GE Healthcare Life 
Sciences) per the manufacturer’s instructions.   
 
Immunoflorescence and immunohistochemistry  
Cellular reactivity of serum autoantibodies was determined by immunofluorescence and 
immunohistochemistry using sera from Aire-KO mice to probe testis, epididymis and 
ovary. Briefly, tissues from Rag2-deficient mice (C.129S6(B6)-Rag2 tm1Fwa, Taconic) 
were flash frozen in dry ice-cooled 2-methylbutane (Sigma-Aldrich) for five minutes prior 
to embedding in OCT (Sakura, Torrance, CA). 10 µm thick sections where 
cryosectioned and fixed in 100% cold acetone for five minutes. Sections were washed 
three times in PBS (pH 7.4), blocked for one hour at room temperature with 2% bovine 
serum albumin (Sigma-Aldrich) supplemented PBS treated for endogenous peroxidase 
activity (0.5% H2O2 in methanol), and incubated overnight at 4°C with serum from WT 
(n=3) and Aire-KO (n=6) mice (1:40 dilution). The following morning the samples were 
washed in PBS and incubated with a goat anti-mouse IgG fluorescent secondary 
antibody (Jackson ImmunoResearch) in the dark at room temperature for 45 minutes 
before being mounted with Prolong Gold containing DAPI (Invitrogen, Carlsbad, CA) 
and viewed on a Nikon 80i fluorescent microscope (KUMC KIDDRC image core). 
Alternatively, samples for immunohistochemistry were washed in PBS and incubated at 
room temperature for 45 minutes with a biotinylated anti-mouse secondary antibody 
(Vector Laboratories, Burlingame, CA). An HRP-Streptavidin conjugate (Invitrogen, 
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Carlsbad, CA) was applied prior to color development with aminoethyl carbazole (AEC 
substrate kit, Invitrogen, Carlsbad, CA). Finally, sections were washed in tap water, 
counterstained with hematoxylin and viewed by light microscopy on a Nikon 80i (KUMC 
KIDDRC image core). 
 
RNA Isolation and qRT-PCR 
To test whether the decidua reaction was impacted by the absence of Aire in mice, 
expression of key genes involved in decidualization were tested by RT-PCR.  RNA was 
extracted from decidual tissue isolated from WT (n=3) and Aire-KO (n=4) embryonic day 
5.5 implantation sites using TRI Reagent (Applied Biosystems, Foster City, CA.). RNA 
concentrations were determined using a BioPhotometer (Eppendorf, Hauppauge, NY) 
and 1µg of RNA was reverse transcribed to cDNA using Superscript III Reverse 
Transcriptase and random primers (Invitrogen, Carlsbad, CA). As controls, 
simultaneous reactions containing water in place of RNA, and reactions without reverse 
transcriptase were included to verify the absence of contamination and genomic DNA, 
respectively. For each sample TaqMan Gene Expression Assay kits (BMP2, 
Mm01340178_m1; CX43, Mm00439105_m1; Dprp, Mm01135453_m1; GAPDH, 
Mm99999915_g1) for real-time RT-PCR were purchased from Applied Biosystems 
(Grand Island, NY) and combined TaqMan Universal PCR Master Mix and 20ng of 
cDNA per the manufacturer’s instructions in an optical reaction plate before being 
amplified using an Applied Biosystems 7300 Real Time PCR machine. All qRT-PCR 
samples were run in triplicate and the mean was created from the three CT values for 
each sample. The mean value was then subtracted from the mean for GAPDH to 
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provide a normalized CT value. These means were then combined to generate an 
average CT value for each decidual marker.  
 
ED5.5 implantation site evaluation 
To determine morphology difference in ED5.5 impanation sites, six-week old WT (n=12) 
and Aire-KO (n=13) females were paired with WT males as described above and 
sacrificed on embryonic day 5.5. Whole implantation sites were removed, fixed in 4% 
PFA overnight, dehydrated in 70% ethanol, embedded in paraffin and stored at 4°C. 
5µm thick serial sections were taken from WT (n=10) and Aire-KO (n=19) implantation 
sites, stained with hematoxylin and eosin (Dako, Carpinteria, CA) and viewed by light 
microscopy on a Nikon 80i (KUMC KIDDRC image core). The section with the widest 
embryo cross sectional area was selected for 2-D area measurements of the whole 
implantation site, region with decidualized cells and the embryo. Area measurements 
were recorded using ImageJ software (NIH, Bethesda, MD).  
 
Blastocyst culture and trophoblast outgrowth 
To determine the embryonic stage prior to implantation and address the ability for 
trophoblast cell to expand in vitro, six-week old WT (n=4) and Aire-KO (n=4) females 
were paired for mating with a WT male and sacrificed on embryonic day 3.5 as 
described above. The collection, staging and culture of ED3.5 blastocysts was 
performed as described by Nagy et al. Briefly, after removing the reproductive tract, 
each uterine horn was isolated by cutting the distal and proximal ends of each uterine 
horn was just below the fallopian tube and just above the cervix, respectively. 
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Blastocysts were flushed from each uterine horn using a 26G needle and 400µl of 
embryonic stem (ES) cell medium (DMEM containing 15% heat-inactivated fetal bovine 
serum, 0.2% glutamine, 0.2% non-essential amino acids, 0.1mM 2-mercaptoethanol, 
0.2% sodium pyruvate and 50u/ml penicillin-streptomycin)  washed through fresh 
microdrops of medium. Each blastocyst was transferred to a single well of a 24-well 
collagen Type I coated plate (EMD Millipore, Billerica, MA) and covered with fresh 
medium. The number and developmental stage of the ED3.5 embryos were determined 
at collection (Nagy et al., 2002). Additionally, images of trophoblast outgrowth were 
recorded on an inverted light microscope 48 and 96 hours post-collection. Total 
outgrowth area was determined for embryos derived from WT by WT (n=30 embryos 
from 4 mice) and Aire-KO by WT (n=30 embryos from 4 mice) breeding pairs using 
ImageJ software (NIH, Bethesda, MD). 
 
Sub-renal transplant surgeries 
To determine whether ovarian phenotype was due to effects of AIRE intrinsic or 
extrinsic to the ovary, wild type ovaries were transplanted into the kidney capsule of 
either Aire-deficient or wild type (control) female mice. Eight-10 week old wild type (n=3) 
or Aire-deficient recipients mice (n=6) were anesthetized as described above. Following 
exteriorization of the kidney, the renal capsule was perforated and an ovary from an 
age-matched WT mouse was maneuvered to the opposite pole of the kidney, after 
which the kidney was returned to the body cavity. The transplant recipient was 
sacrificed after 10 days, and the transplanted ovary together with the kidney and 
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Duration to initial mating, progesterone levels, weight change, gene expression, 
implantation site area, trophoblast outgrowth area and number of ovulation between 
wild type controls and Aire-deficient mice were analyzed by two-tailed Student’s T test. 
Percentages of mice that mated, ovulated, had implantation sites at sacrifice were 
compared by Chi-square analysis. Additionally, the percentage of healthy oocytes and 
the percent of ovulated oocytes to reach 2-cell stage and blastocyst stage were 


















Our initial study of the infertility in female Aire-deficient mice (Jasti et al., 2012) revealed 
ovarian immune targeting resulting in premature depletion of follicular reserves 
impacting approximately 60% of animals by 16-weeks of age. To determine the targets 
of an anti-ovarian immune response resulting in follicular depletion we probed an 
immunoblot of ovarian protein lysates from a Rag-deficient female mouse with serum 
collected from 6-8 week old mated WT and Aire-KO female mice with histologically 
normal ovaries. Nine of the 15 serum samples from Aire-KO females revealed unique 
reactivity not detected in serum from WT mice (Figure 2.1A). Next, we determined the 
cellular localization of antigenic targets by indirect immunostaining of frozen ovary 
sections from Rag-deficient mice. Compared to WT controls, serum autoantibodies from 
Aire-KO mice bound to multiple targets including stromal cells, luteal cells and the 
oocyte (Figure 2.1B).  
Because expression of Aire mRNA has been reported in the ovary (Anderson et al., 
2002; Halonen et al., 2001), we next sought to determine whether the altered ovarian 
environment in Aire-KO female mice is due to direct autoimmune targeting or an ovary 
intrinsic role of AIRE. To this end, we grafted WT ovaries under the kidney capsule of 
either WT controls (n=2) or Aire-deficient females (n=6). The health of the transplanted 
tissue was examined 10 days after the procedure. Ovaries transplanted to WT  
 







Figure 2.1: Anti-ovary immune response. (A) Rag-KO ovarian lysate was probed with 
serum from WT and Aire-KO female mice. All serum samples are from mice 
approximately 7-8 weeks of age. (B) Ovaries from Rag-KO mice were stained by 
immunohistochemistry using serum from WT or Aire-KO mice. Images are 200x. (C) WT 
(left) or Aire-KO (right) female mice were engrafted with a donor WT ovary under the 
kidney capsule and sacrificed after 10 days. Images are 100x. WT, wild type; KO, AIRE-
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recipients appeared healthy and revealed no signs of follicular loss. However, ovaries 
engrafted to Aire-KO females, whose own endogenous ovaries lacked follicles (4 of 6), 
displayed complete follicular depletion together with leukocytic infiltration (Figure 2.1C).  
  
Fertility in female Aire-deficient mice. 
 
Ovarian lymphocyte inflammation in Aire-KO mice precedes complete follicular loss 
(Jasti et al., 2012). To determine the impact of this autoimmunity on pregnancy we 
assess a variety of fertility parameters in six-week old congenic (>8 generations) Aire-
deficient female mice on the Balb/c genetic background with histologically normal 
ovaries (determined post-mortem). Aire-KO females demonstrated no difference in the 
length of time to initial mating or in the percentage of mice that mated and successfully 
ovulated oocytes (Figure 2.2A, B, C).  
We found that 50% of six-week old Aire-KO female mice were unable to produce a first 
litter despite over 90% (n=78) of animals having a normal complement of ovarian 
follicles. To assess the timing of embryonic loss in six-week old Aire-KO female mice we 
sacrificed animals on embryonic day (ED) 5.5, 7.5 and 10.5 following the detection of a 
copulatory plug and looked for the presence of healthy implantation sites. There was no 
difference in the percentage of pregnant females at ED5.5. However, there was a 
significant reduction in fertility at both ED7.5 and 10.5 (Figure 2.3A). The timing of 
pregnancy loss corresponded with growth curves recorded over the first half of 
pregnancy (Figure 2.3B). To address a possible cause of embryonic loss infertility, we  
 







Figure 2.2: Timing of follicular loss and fertility parameters in AIRE deficient mice. 
(A) Mean duration between pairing and initial mating for six-week old WT and Aire-KO 
females. (B) Mean percentage of six-week old WT controls and Aire-KO females that 
produced a copulatory plug. (C) Mean percentage of six-week old WT and Aire-KO 
females to ovulate oocytes at ED0.5. WT, wild type; KO, AIRE-deficient mice; ED, 





















































































Figure 2.3: Timing of embryonic loss, pregnancy-associated weight gain and 
progesterone production. (A) Mean percentage of six-week old WT and Aire-KO 
female mice with implantation sites at ED5.5, 7.5 and 10.5. (B) Weight deviation from 
baseline at ED0.5 through ED10.5 in mated six-week old WT and Aire-KO females. (C) 
Mean values for serum progesterone. WT, wild type; KO, AIRE-deficient mice; ED, 
embryonic day. Ŧ, P < 0.05 by chi-square analysis;  *, P < 0.05 by students t-test; **, P < 
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measured serum concentration of progesterone in mated WT controls as well as in and 
Aire-KO females, both with and without the presence of implantation sites at collection. 
All mice, regardless of genotype or pregnancy status had comparable progesterone 
levels at ED5.5. However, at ED7.5 and 10.5, serum progesterone was significantly 
reduced in non-pregnant females compared to pregnant animals of both genotypes 
(Figure 2.3C). 
 
Female reproductive tract autoantibodies. 
 
We next assessed the possibility that autoantibodies are generated in Aire-kO females 
against the uterus, placenta, embryo and testis protein lysates. To this end, tissue 
lysates were probed by immunoblot analysis using serum collected from WT and Aire-
KO female mice. While serum from Aire-deficient mice displayed stronger reactivity 
towards female reproductive tract tissue antigens in general, no clear specific reactivity 
was detected when compared to WT controls (Figure 2.4A, B, C). Interestingly, both 
mated WT and Aire-KO females demonstrated increased reactivity against male 
testicular lysate compared to virgin animals. However, mated female Aire-deficient mice 
produced stronger reactivity and unique autoantibodies not seen in mated WT samples 
or samples from virgin mice of either genotype (Figure 2.5A). We confirmed specificity 
to sperm by probing frozen tissue sections of testis and epididymis from a Rag-deficient 
mouse with a selected serum sample (arrow head) (Figure 2.5A). Autoantibodies within 
serum samples from mated Aire-KO mice bound to testicular and epididymal sperm 
(Figure 2.5B).  







Figure 2.4: Serum autoantibodies against uterus, placenta and embryo. Rag-KO 
protein lysate from (A) uterus (B) placenta and (C) whole embryo were probed with 
serum from WT and Aire-KO female mice. In each blot, columns 1-5 contain WT serum 
and columns 6-20 contain Aire-KO serum. All serum samples are from mated mice 
approximately 7-8 weeks of age. WT, wild type; KO, AIRE-deficient mice; Rag-KO, 


























Figure 2.5: Mating induced generation of anti-sperm antibodies. (A) Rag-KO sperm 
lysate was probed with serum from virgin and mated WT and Aire-KO female mice. All 
serum samples are from mice approximately 7-8 weeks of age. (B) Aire-KO serum on 
frozen Rag-KO tissue sections. All images are 200x. Arrow indicates selected serum 
sample used for Fig. 4B. WT, wild type; KO, AIRE-deficient mice; Rag-KO, 
Recombinase Activation gene-1 deficient mice; EpTu, Epididymal tubules; SeTu, 
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Histopathology of embryonic day 5.5 implantation sites and decidual marker gene 
expression.  
 
We next performed histopathological evaluation of implantation sites from WT by WT 
and WT by Aire-KO mating pairs collected at ED5.5. No clear immune infiltration was 
noted. However, implantation sites from Aire-KO females were smaller and extensive 
gastrulation of the embryo was only seen in embryos from WT females (Figure 2.6A).  
Aire mRNA has been detected in the decidual stroma at gestational day 10.5 (Zhang et 
al., 2012).  Therefore, Aire has a possible function in the decidua and to examine 
whether impaired decidualization of the uterine stroma could be responsible for smaller 
implantation sites or pregnancy loss observed at later time points, we analyzed gene 
expression of BMP2, CX43 and Dprp from isolated decidual tissue (Figure 2.6B). There 
was no difference in gene expression of these decidual markers between genotypes. To 
confirm the apparent size reduction we took area measurements of the total 
implantation site under the uterine musculature, the region containing the secondary 
decidual zone and that of the embryo (Figure 2.6C). The area measurements for all 
three were significantly smaller in implantation sites from Aire-KO females compared to 













Figure 2.6: Evaluation of implantation sites and gene expression decidualization 
markers at embryonic day 5.5. (A) Histopathology of ED5.5 implantation sites from 
pregnant WT and Aire-KO female mice. (B) Relative gene expression values for BMP2, 
CX43 and Dprp from isolated decidua from ED5.5 implantation sites. (C) 2-D area 
measurements of total implantation site, decidualized region and embryo taken from the 
serial section with the largest embryonic cross sectional area. All images are 40x. Bars 
represent median. Dashed lines in Fig. 5A are examples of regions used for 
measurements in Fig. 5C. WT, wild type; KO, AIRE-deficient mice; BMP2, Bone 
morphogenetic protein 2; CX43, Connexin 43; Dprp, Decidual prolactin related protein; 
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In vitro culture of embryonic day 0.5 embryos.  
 
To address the possibility of delayed embryo development, we cultured ED0.5 embryos 
from six-week old WT controls and Aire-KO females mated with WT males. Although 
the total number of ovulations was comparable between genotypes (Figure 2.7A), the 
number of degenerated oocytes from Aire-KO females was increased (Figure 2.7B). 
Embryos from WT by WT breeding pairs developed to 2-cell and blastocyst stage with a 
success rate of 76% and 60%, respectively. Comparatively, embryos from Aire-KO 
females were significantly reduced in their ability to reach the 2-cell and blastocyst 
stage of development with a success rate of 47% and 19%, respectively (Figure 2.7C, 
D). Compared to WT controls, of which 78% of 2-cell stage 
 
In vitro blastocyst culture and trophoblast outgrowth. 
 
Next we confirmed the delayed development by collecting ED3.5 blastocysts from six-
week old WT and Aire-KO female mice that had been bred to WT males. 80% (24 of 30) 
blastocysts from WT females had a blastocyst cavity at collection on ED3.5, compared 
to 20% (6 of 30) of embryos from Aire-KO females. Of the remained 24 embryos, nine 
(30%) were morulla and 15 (50%) were between the 2 and 8-cell stage (Figure 2.8A, 
B). Collected blastocysts were then cultured to assess trophoblast outgrowth potential. 
By 48 hours post-collection, 87% of blastocysts from WT females had evidence of 
outgrowth compared to only 17% of blastocysts from Aire-KO females (Figure 2.8A, C). 
By 96 hours post-collection, all  







Figure 2.7: In vitro embryo culture. (A) Mean number of ovulations from mated six-
week old WT and Aire-KO female mice. (B) Mean percentage of visually healthy 
oocytes collected at ED0.5 from mated six-week old WT and Aire-KO female mice. (C) 
Mean percentage of ED0.5 oocytes to reach 2-cell stage 24 hours post-collection. (D) 
Mean percentage of ED0.5 oocytes to reach blastocyst stage 72-96 hours post-





















































































































Figure 2.8: In vitro blastocyst culture. (A) Representative images of embryos from 
mated WT and Aire-KO female mice collected at ED3.5 and then cultured on collagen 
coated plates for 48 and 96hrs. (B) Assessment of embryonic stage at collection. (C) 
Individual area measure of trophoblast outgrowth from WT and Aire-KO embryos 48 
and 96hrs post-collection. All images are 100x. Bars represent median. WT, wild type; 
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blastocysts from WT females had outgrowth compared to 63% of blastocysts from Aire-
KO females (Figure 2.8A, C). At both time points the total outgrowth area was 
significantly larger for blastocysts from WT females compared to those from Aire-KO 
females (Figure 2.8C). Embryos progressed to blastocyst, only 40% of embryos from 
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DISCUSSION  
 
The discovery of the Autoimmune Regulator (AIRE) and an appreciation of its role in 
central immune tolerance have changed our understanding of how the immune system 
becomes tolerized towards tissue specific antigens. AIRE-regulated gene transcription 
within the thymus leads to generation of self-peptide antigens necessary for the 
elimination of autoreactive T cells during their development (Anderson et al., 2002; 
Derbinski et al., 2005). Many of the genes controlled by AIRE, some of which are highly 
restricted in their non-thymic tissue distribution, are endogenous to the female 
reproductive tract as well as the developing placenta and embryo (Derbinski et al., 
2001). A disruption of this gene in humans results in a condition known as the 
Autoimmune Polyendocrine Syndrome Type-1 (APS-1), which is a multi-organ 
autoimmune disease characterized by autoreactive CD4+ T cells and antibodies 
(Ahonen, 1985; Ramsey et al., 2002; Vogel et al., 2002). An engineered ablation of this 
gene in mice mimics many of the autoimmune endpoints seen in humans, including 
elevated rates of gonadal insufficiency (Anderson et al., 2002; Hubert et al., 2009; Jasti 
et al., 2012). In this study, we investigated the impact of ovarian autoimmune disease 
on fertility and oocyte quality in six-week old Aire-deficient prior to the premature 
depletion of their ovarian follicles, which is a hallmark of these mice on the Balb/c 
genetic background (Jasti et al., 2012).  
Excluding the diagnostic triad for APS-1 of adrenal failure, hypoparathyroidism and 
candidiasis, gonadal insufficiency is the most common aliment in females, impacting 
55% of patients by 20 years of age (Ahonen et al., 1990; Neufeld, Maclaren, & Blizzard, 
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1981; Vaidya et al., 2000). We have previously shown that this condition is mirrored in 
Aire-deficient mice, of which 60% demonstrate premature follicular senescence by 16 
weeks of age. However, we have found that in 2-3 month old mice, which still have 
histologically normal ovaries, there is still a 50% rate of infertility. Initial investigation into 
the timing of embryo loss in Aire-deficient mice revealed comparable fertility rates just 
after implantation with complete embryonic loss being evident by embryonic day 7.5 
(Figure 2.3A). This led us to assess possible post-ovulation causes of infertility 
including defects in progesterone production, decidualization of uterine stromal cells 
and the presence of autoantibodies specific for the placenta, uterus and embryo. 
Ultimately, we excluded these possibilities as the cause of pregnancy loss. Considering 
that APS-1 patients are known to generate a wide range of autoantibodies, of which 
large percentages are steroid cell specific (Krohn, Uibo, Aavik, Peterson, & Savilahti, 
1992; Uibo, Perheentupa, Ovod, & Krohn, 1994; Winqvist et al., 1995), we were 
surprised that the non-pregnant Aire-deficient mice scarified at ED5.5 had comparable 
levels of serum progesterone (Figure 2.3C). The lack of progesterone at later time 
points likely reflects an absence of a positive feedback signal from placental lactogen 
(Soares & Talamantes, 1983; Talamantes, Ogren, Markoff, Woodard, & Madrid, 1980), 
since 50% of nonpregnant animals at ED7.5 and 10.5 lacked any detectable 
implantation sites, either healthy or resorbing. Next we considered a defect in 
decidualization as a mechanism for the lack the implantation sites in the nonpregnant 
females. However, isolated decidual tissue from implantation from Aire-KO females 
collected at ED5.5 had normal expression of three decidual specific genes (Figure 
2.6B). Although we cannot formally rule out defective decidualization without directly 
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testing the decidua response in hormone-primed, unmated animals, the normal level of 
gene expression argues strongly that this is not the case. Finally, although we found an 
increase in the strength of autoantibody reactivity against placental, uterine and 
embryonic tissue compared to controls (Figure 2.4), the patterns of autoantibody 
reactivity were similar between WT and KO animals, without evidence of unique 
antibodies within Aire-KO serum. While we cannot complete discard the possibility that 
an over production of antibodies may be pathogenic we considered this unlikely as 
previous reports have failed to reproduce disease symptoms with serum transfer 
(Gavanescu et al., 2008).  
Sperm specific antibodies are considered clinically significant when assessing infertility 
if more than 50% of the spermatozoa are coated in antibodies, fertilization is impaired 
and/or if there is a defect in the ability of sperm to penetrate the preovulatory cervical 
mucosa (N. J. Alexander, 1984; Heidenreich, Bonfig, Wilbert, Strohmaier, & Engelmann, 
1994; Witkin & Toth, 1983). We were able to detect the generation of antisperm 
antibodies in the serum of previously bred Aire-deficient females (Figure 2.5). However, 
fertilization rates, as determined by the presence of the male pronuclei within the ovum 
(Jasti et al., 2012), were comparable between genotypes, suggesting that a sperm 
specific immune response is not responsible for the primigravida infertility.   
The peri-implantation embryonic demise witnessed in six-week-old Aire-KO mice could 
have been the consequence of an anti-ovarian immune response that reduced oocyte 
quality prior to ovulation. Indeed ovarian antigens can drive an autoimmune response 
(P. Fenichel et al., 1997; Hoek et al., 1997; Tong & Nelson, 1999; Tung et al., 1987; 
Wheatcroft, Toogood, Li, Cooke, & Weetman, 1994) and previous studies have noted 
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the presence of antibodies specific for the oocyte and granulosa cells (Anderson et al., 
2002). While we have not identified the responsible antigens for ovarian autoimmune 
disease in Aire-deficient mice, we do have multiple lines of evidence supporting that it is 
targeted. First, we have previously identified abnormal T cell accumulation within the 
ovaries of Aire-deficient mice as early as three-weeks of age. Second, serum from Aire-
deficient mice contains autoreactive antibodies that are largely specific for proteins in 
the 60 and 75 kDa range and localize to multiple ovarian cell types including stomal 
cells, luteal cells and the oocyte (Figure 2.1A, B). Third, WT ovaries transplanted under 
the kidney capsule of Aire-KO experienced near complete follicular depletion in as short 
as ten days (Figure 2.1C). This result was only witnessed if the endogenous ovary of 
the transplant recipient was similarly devoid of oocytes, suggesting a rapid ovary-
specific memory response. Ultimately, the outcome of this response was realized in the 
post-ovarian phenotype of the ovulated oocytes. Ovulated oocytes were degenerated at 
a significantly higher percentage (Figure 2.7B) and impaired in their ability to progress 
to the 2-cell and blastocyst stages of development (Figure 2.7C, D). Importantly, this 
observation was not just a consequence of culture conditions as embryos isolated from 
mated Aire-KO females just prior to implantation where often significantly delayed, with 
only 20% of embryos progressing beyond morulla (Figure 2.8A, B).  
Diminished oocyte quality and reduced fertility are natural components of the age-
related process of follicular senescence (Armstrong, 2001; Fitzgerald, Zimon, & Jones, 
1998). Multiple in vitro fertilization and ovum donation studies have clearly linked 
declining oocyte quality due to aging with decreased pregnancy rates and impaired 
implantation (Cetin, Kumtepe, Kiran, & Seydaoglu, 2010; Chuang et al., 2003; Navot et 
	   107	  
al., 1991). One possible explanation is that the process of follicular senescence results 
in low quality oocytes that, if fertilized, progress through the developmental stages at a 
rate that is not compatible with fertility. The steps between ovulation and implantation 
are complex and involve precise coordination between the embryo and the hormone 
responsive uterine environment (Paria, Reese, Das, & Dey, 2002). Successful 
implantation requires synchronization between the embryonic stage and the window 
uterine receptivity (Ma, Song, Das, Paria, & Dey, 2003). Changes in hormone levels, 
developmental stage and gene expression can derail this alignment and result in 
infertility (Dickman & Noyes, 1960; Palomino et al., 2005; Reese et al., 2001). It is 
possible that the infertility in 50% of Aire-deficient female mice is a result of an 
imbalance between these two components, resulting in embryonic demise shortly after 
implantation. A clear limitation of this study is that we did not completely isolate a 
uterine effect from an embryonic one. It may be necessary in the future to preform 
reciprocal blastocyst transfers into hormonally primed recipients female mice to confirm 
our assertion of infertility secondary to low oocyte quality resulting in embryonic 
developmental delay.  
The discovery of the AIRE gene and its contribution to central tolerance has exposed 
new possibility for investigation into the mechanisms responsible for organ specific 
immune tolerance. AIRE induces the ectopic thymic expression of many genes that are 
also found in the ovary, placenta and embryo which are, especially with regards to the 
ovary, essential for fertility preservation. Here, we show that a deficiency in Aire in 
female mice results in autoimmune recognition of the ovary that culminates in low 
quality oocytes. Subsequently, these oocytes are more frequently degenerated at 
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ovulation, are impaired in their ability to become 2-cell and blastocyst stage embryos in 
vitro, are developmentally delayed at implantation and ultimately fail to maintain a viable 
pregnancy. This demonstration of the impact of ovarian autoimmune disease on oocyte 
health has implications not only for APS-1 patients but also extends our understanding 
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ABSTRACT 
 
Male-specific factors, including those with noninfectious autoimmune origins, 
contribute to approximately 50% of all infertility cases. However, an understanding of 
the etiologies and mechanisms behind autoimmune male infertility remain poorly 
understood, despite recognition that infertile males often develop antisperm antibodies. 
A deficiency of the autoimmune regulator (AIRE) gene impairs central immune tolerance 
by inhibiting the expression of thymic self-antigens. As a consequence, humans, as well 
as mice with an engineered ablation of Aire, develop a multi-organ autoimmune disorder 
that presents with elevated rates of infertility. The consequences of incomplete central 
immune tolerance on male fertility are still being determined. As such we sought to 
document the exact autoimmune targets contributing to infertility in male Aire-deficient 
(KO) Balb/c mice. In this study, 6-week old Aire-KO males exhibited reduced frequency 
of mating (46% KO vs. 100% WT; n=11 and 10 respectively P<0.05) and fertility (18% 
KO vs. 80% WT; n=11 and 10 respectively P<0.05) as well as potentially low litter size 
(2.00 vs. 5.08 pups/litter; n=2 and 10 respectively). Further investigation revealed 
primary hypogonadism with reduced serum testosterone (p=0.03; n=18), but a normal 
sperm count and pituitary gonadotropins. In addition, mature spermatozoa were 
consistently defective in their ability to fertilize wild-type oocytes in vitro (9%; vs.54%; 
n=102 and 83 oocytes respectively P<0.05). A subset of males exhibited severe 
oligozoospermia, fewer mitotically active germ cells and disruption of the blood-testis 
barrier. Morphologic alterations to the stroma and luminal epithelium of the epididymis, 
as well as the glands associated with the vomeronasal organ, occurred in 32% and 86% 
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of animals, respectively. Correspondingly, CD3+ T cell infiltration into the testis, 
epididymis, seminal vesicle, and prostate was evident in 5%, 75%, 84% and 90% of 
animals respectively. Finally, Aire-KO male mice generate autoreactive antibodies in an 
age-dependent manner against various components of the male reproductive tract, 
including sperm, testis, epididymis, prostate gland and seminal vesicle. Collectively, 
these findings reveal two important aspects of autoimmune infertility in Aire-KO male 
mice. First, the disorder has a high degree of heterogeneity between individual animals 
and is multifactorial within animals. Second, Aire-dependent central immune tolerance 
plays an integral role in maintaining fertility by stemming autoimmunity against multiple 
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INTRODUCTION 
 
Infertility is estimated to affect 9-15% of reproductive-aged couples worldwide (Boivin et 
al., 2007; Rutstein & Shah, 2004). In the past, compromised fertility often was attributed 
by default to female pathologies, and our relatively broad knowledge base and range of 
treatment options reflect such a basis. However, it is now understood that roughly one-
half of all infertility cases are caused by male-specific factors (Jarow et al., 2002). While 
many cases of male infertility are idiopathic, some of the known causes of male infertility 
include genetic and hormonal lesions at the pre-testicular level, oxidative stress, sperm 
arrest, and germ cell DNA damage within the testis.  Post-testicular causes for infertility 
in men include infection, inflammation and congenital abnormalities associated with 
obstruction of sperm transport (Esteves, Hamada, Kondray, Pitchika, & Agarwal, 2012; 
Sullivan, 2004). 
The immune system is tasked with identifying and removing foreign pathogens while 
remaining tolerant to self-antigens, including those associated with the reproductive 
system in both males and females. Thus, fertility preservation in males requires 
simultaneous tolerance to the immunogenic antigens on developing germ cells while 
also controlling the potentially damaging influence of reproductive tract infections 
(Baker, 1998; Suri, 2004). In addition, autoimmune and inflammatory diseases and 
associated orchitis, epididymitis, and autoantibodies are estimated to be associated with 
as many as 10% of all male-factor derived infertility cases (Jungwirth et al., 2012). 
Autoimmunity is the loss of immunologic self-tolerance and results in continual 
recognition and response against self-antigens by the adaptive immune system. These 
conditions and an individual’s susceptibility have proven difficult to study as they often 
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involve both host genetics and environmental factors (Marrack et al., 2001). Rare cases 
of monogeneic disorders leading to autoimmunity, as exemplified by polymorphisms in 
the gene encoding the autoimmune regulator (AIRE), can provide novel insight into the 
mechanisms behind these diseases (Akirav et al., 2011; Kyewski & Derbinski, 2004). 
Autoimmune polyglandular syndrome type I (APS-1)(Ahonen, 1985), a disease resulting 
from a deficiency in AIRE, is characterized by autoimmune destruction of multiple 
organs and high serum titers of autoantibodies (Soderbergh et al., 2004). Clinically, the 
diagnostic criterion for APS-I requires patients to present with two of the following three 
pathologies: adrenal insufficiency, chronic mucocutaneous candidiasis and 
hypoparathyroidism (Ahonen et al., 1990; Bjorses et al., 1996). Additionally, patients 
often develop a broad range of secondary autoimmune-mediated complications, 
including elevated rate male infertility (Ahonen et al., 1990).  
 
The AIRE gene encodes a 58-kDa protein that is predominately expressed by medullary 
thymic epithelial cells (mTEC) (Bjorses et al., 1996; Heino et al., 2001) and that 
possesses structural and functional attributes suggestive of a transcription factor 
(Anderson et al., 2002; Nagamine et al., 1997). While the exact mechanism remains 
unclear, AIRE, through its molecular motifs and various binding partners, has a vital role 
in establishing central immune tolerance by regulating the “promiscuous” expression 
and presentation of numerous tissue-specific self antigens in mTEC (Abramson et al., 
2010; Anderson et al., 2002; Derbinski et al., 2005; Derbinski et al., 2001; Kuroda et al., 
2005; Nagamine et al., 1997). Importantly, developing autoreactive T cells are removed 
following exposure to these self-antigens (Anderson et al., 2005; Liston et al., 2003). 
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Included within the battery of AIRE-regulated antigens are those found within, and even 
exclusive to, the male reproductive system (Derbinski et al., 2005).  
 
Disruption of the murine Aire gene, which shares 71% homology with its human 
counterpart (Halonen et al., 2001), effectively models many of the key attributes of APS-
1. Importantly, Aire-deficient mice have a significantly altered thymic self-antigen 
expression profile, which causes inappropriate escape of self-reactive T cells and 
culminates in development of autoreactive CD4+ T cell and serum autoantibodies 
(Anderson et al., 2002; Derbinski et al., 2005; Hubert et al., 2009; Kuroda et al., 2005; 
Ramsey et al., 2002). In addition, disease onset and severity is highly variable both 
within and between genetic backgrounds (Jiang et al., 2005). Interestingly, several 
reports comment on decreased fertility in male Aire-deficient mice as well as the 
frequent occurrence of immune mediated prostatitis (Anderson et al., 2002; Hou et al., 
2009; Hubert et al., 2009; Kuroda et al., 2005; Ramsey et al., 2002). However, neither a 
detailed evaluation of the autoimmune disease occurring within the reproductive track, 
nor the causal influences leading to infertility in male Aire-deficient mice have been 
examined. In the present study we explore the consequence of a disruption of AIRE-
mediated gene expression on fertility and examine which reproductive organs are the 
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METHODS AND MATERIALS 
 
Animals 
Aire-deficient mice on the Balb/cJ genetic background (>8 generations) (Anderson et 
al., 2002; Jiang et al., 2005) were a generous donation to our laboratory by C. Benoist 
and D. Mathis (Harvard Medical School, Boston, MA). Mice were housed under 
pathogen-free condition at the University of Kansas Medical Center (KUMC). All 
experiments both complied with NIH Guidelines for the Care and Use of Laboratory 
Animals and were approved by the Institutional Animal Care and Use Committee at 
KUMC. The Aire-KO male mice used in these experiments were generated using 
heterozygous breeders. Wild type (WT) Balb/cJ males and females were obtained from 
The Jackson Laboratory (Bar Harbor, ME, USA). Genotypes were confirmed by PCR 
using the following primer set: FWD 5’ GTCCCTGAGGACAAGTTCCA 3’; REV 5’ 
GGGACTGGTTTAGGTCCACA 3’. WT mice generate a 758 bp product, Aire-KO mice 
yield a 297 bp product and heterozygous animals produce both.  
 
Fertility Assessment 
Fertility was evaluated in 6-week-old Aire-KO males (n=11) and wild type controls 
(n=12). Male mice were cohabitated with a single Balb/c WT female and checked daily 
for the presence of a copulatory plug. If a plug was detected, the male was removed 
and euthanized for blood and tissue collection. The females were allowed 23 days post-
mating to deliver pups and the offspring were counted if a viable litter was produced. If a 
plug was not visually confirmed over a period of 20 days (approximately four ovarian 
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cycles), the male was euthanized and the female was permitted 21 days of isolation to 
verify absence of pregnancy before being mated to a proven WT Balb/c male to confirm 
the female’s fertility.  
 
Blood and Tissue collection 
Wild type and Aire-deficient males were sacrificed for the collection of blood and male 
reproductive tract tissues. Mice were anesthetized with a sterile solution of Avertin 
(2,2,2-Tribromoethanol  dissolved in 2-methyl-2-butanol) (250mg/kg intraperitoneal (IP)) 
(Sigma-Aldrich, St. Louis, MO). Serum was collected under anesthesia via cardiac 
puncture and stored at -20°C. Mice were then euthanized via cervical dislocation and 
opening of the cardiac cavity, following which the testis, epididymis, seminal vesicle, 
prostate gland and vomeronasal organ (VNO) were removed, weighed, fixed in 4% 
paraformaldehyde overnight, dehydrated in 70% ethanol, embedded in paraffin and 
stored at 4°C. The vomeronasal organ samples required an additional seven day 
incubation in 0.25% EDTA at 4°C (changed every 48 hours) to decalcify the nasal cavity 
bones before paraformaldehyde fixation.  
 
Determination of serum FSH, LH and Testosterone  
Mouse serum FSH and testosterone were measured by radioimmunoassay at the 
University of Virginia Center for Research in Reproduction Ligand Assay and Analysis 
Core (Charlottesville, VA). The sensitivities of the assays are 2.0 ng/ml and 10ng/dL 
with a range of 2.0-25 ng/mL and 10-1000 ng/dL respectively. Mouse serum LH was 
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also measured at the University of Virginia by sandwich immunoradiometric assay. The 
sensitivity of the assay is 0.07 ng/mL with a range of 0.07-37.4 ng/mL.  
 
Caudal Sperm Count 
To determine epididymal sperm counts, the caudal region of epididymis from WT and 
Aire-KO mice were isolated, weighed and placed into 750µl of Human Tubal Fluid (HTF) 
media (EMD Millipore, Billerica, MA). The tissue was bisected and the sperm were 
allowed to swim out and complete capacitation for one hour at 37 °C. Finally, the 
number of sperm from a 10µl aliquot diluted in 990µl of PBS, was determined by a 
hemocytometer and normalized to the weight of the tissue. 
 
Histopathologic evaluation and immunohistochemistry  
For histopathologic examination, paraformaldehyde fixed and paraffin embedded 
reproductive tract tissues were sectioned at 5µm thickness and stained with 
hematoxylin and eosin (Dako, Carpinteria, CA). Tissues from Aire-KO males were 
compared to WT controls for morphologic differences and immune cell infiltrates. 
Immunohistochemistry was used for detection of CD3, ZO-1 and Ki67 positive cells 
within the tissues of the male reproductive tract of Aire-KO (n=6-10) and WT controls 
(n=3-5). Sections were rehydrated through decreasing concentrations of ethanol. 
Antigen retrieval was performed using a heated citrate buffer (Reveal buffer, BioCare 
Medical, Walnut Creek, CA) according to the manufacturer’s instructions. Tissues were 
then blocked in 10% goat serum (Sigma-Aldrich, St. Louis, MO) prior to a 16 hour 4°C 
incubation with a monocolonal rabbit anti-mouse CD3 antibody at 4°C (5µg/ml, clone 
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SP7; Abcam Cambrige, MA). Rabbit IgG (5µg/ml, chromPure, Jackson 
ImmunoResearch, West Grove, PA) was used as a negative control. Sections were 
then incubated with a biotyinylated anti-rabbit secondary antibody (goat anti-rabbit IgG 
BA-1000, Vector Laboratories, Burlingame, CA), followed by depletion of endogenous 
peroxidases and addition of streptavidin peroxidase substrate (Invitrogen, Carlsbad, 
CA). Colorimetric detection was visualized using aminoethyl carbazole (AEC substrate 
kit, Invitrogen). Finally, sections were counterstained with hematoxylin and viewed by 
light microscopy on a Nikon 80i microscope (KUMC KIDDRC image core). For detection 
of Ki67 (1/200) (Thermo, SP6 clone, Pittsburg, PA) and ZO-1 (2mg/ml) (Life 
Technologies, 617300, Grand Island, NY), identical procedures were used, except that 
antigen retrieval for the ZO-1 staining required a five minute incubation with 0.1% 
proteinase kinase at 37°C in place of the citrate buffer.  
To assess the mean number of mitotically active germ cells per tubule, 5µm thick testis 
sections were stained for Ki67. The numbers of positive nuclei were quantified from and 
normalized to the number of tubules within five random 20x fields per section.  
 
Immunoblotting 
WT and Aire-KO mouse serum was used to probe testis, caput, cadua, seminal vesicle, 
prostate and sperm lysates from Rag2-deficient mice (C.129S6(B6)-Rag2 tm1Fwa, 
Taconic) for the presence of autoantibodies. The tissue was homogenized on ice in 
RIPA buffer and then boiled for five minutes in a buffer containing 10% glycerol, 40mM 
Tris (pH 6.8), 1% SDS, 10% 2-mercaptoethanol and 0.01% bromophenol blue. 400µg of 
lysate was run on a 4-20% TGX stain-free curtain gel (BioRad, cat# 567-8091, 
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Hercules, CA) and transferred to a Whatman Protran nitrocellulose membrane (GE 
Healthcare Life Sciences) at 100 V for 20 minutes. The membrane was blocked for 3 
hours at room temperature with a 3.5% solution of BSA (Sigma-Aldrich) in PBS (pH 7.4) 
before being placed inside a Mini-Protean II Multiscreen apparatus (BioRad). Serum 
(1:750 dilution) from WT (n=5) and Aire-KO (n=15) mice was loaded into the slots and 
incubated at 4°C for 18 hours. The membrane was washed several times with PBS 
containing 0.1% Tween 20 and then incubated with an HRP conjugated anti-mouse 
secondary antibody (Sigma-Aldrich). Immunoreactivity was visualized with an ECL 
detection kit (GE Healthcare Life Sciences) per the manufacturer’s instructions.   
 
Immunoflorescence  
Cellular reactivity of serum autoantibodies was determined by immunofluorescence 
using sera from Aire-KO mice to probe testis, epididymis, seminal vesicle and prostate 
gland. Briefly, male reproductive tract tissues from Rag2-deficient mice were flash 
frozen in dry ice-cooled 2-methylbutane (Sigma-Aldrich) for five minutes prior to 
embedding in OCT cryoprotective medium (Sakura, Torrance, CA). Ten-µm thick 
sections where cryosectioned and fixed in 100% cold acetone for five minutes. Sera 
(1:40 dilution) from WT (n=3) and Aire-KO (n=6) mice were used as  probes, and bound 
antibodies were visualized with a goat anti-mouse IgG fluorescent secondary antibody 
(Jackson ImmunoResearch). To determine whether endogenous autoantibodies were 
bound within the cauda of the epididymis, FITC-labeled goat anti-mouse IgG antibody 
was applied directly onto cryosections from WT and Aire-deficient mice. All sections 
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were coverslipped usingProlong Gold containing DAPI (Invitrogen) and viewed on a 
Nikon 80i fluorescent microscope.  
 
In vitro fertilization 
Sperm from wild type (n=7) and Aire-KO (n=8) male mice was used to fertilize oocytes 
obtained from superovulated WT females in vitro. Briefly, female mice were given 
pregnant mare’s serum gonadotropin (PMSG; 5IU/ml) IP at 9pm on day 1, followed by 
human chorionic gonadotropin (hCG;5 IU/ml, IP) at 9pm on day 3. Female mice were 
sacrificed 12 hours later and the oocytes were flushed from the ampulla region of the 
oviduct, washed through three microdrops of FHM-Hepes (EMD Millipore, Billerica, MA) 
and placed in a culture dish with HTF media. To collect sperm, males were sacrificed on 
the same day, and caudal epididymis was dissected and incubated at 37°C in 1ml of 
HTF for at least 90 minutes. Capacitated sperm (1-2x106) was incubated with collected 
oocytes at 37°C for an additional 4-6 hours. Potentially fertilized oocytes were washed 
and stored in microdrops of KSOM with amino acids and D-glucose (EMD Millipore, 
Billerica, MA). Embryos were visualized on an inverted light microscope 24 and 96 
hours post fertilization, and the numbers and stages of embryos recorded.  
 
Statistical Analysis 
Hormone values, caudal sperm count, Ki67+ cells per seminiferous tubule and testis 
weights between wild type controls and Aire-deficient mice were analyzed by two-tailed 
Student’s T test. Percentages of mice that were capable of mating, producing viable 
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offspring, having normal VNO-associated glands and IVF results were compared by 
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RESULTS 
 
Assessment of fertility in male Aire-deficient mice. 
 
Initial studies describing the Aire-deficient mice suggested that males are either 
subfertile or infertile (Anderson et al., 2002; Hubert et al., 2009; Kuroda et al., 2005; 
Ramsey et al., 2002). Here, we examined the detailed fertility parameters of Aire-KO 
male mice as compared to WT control mice on the same genetic background. Aire-KO 
males demonstrated a significant reduction in the ability to produce a copulation plug 
and the ability to produce viable offspring compared to controls (Figure 3.1A, B). In 
addition, when offspring were observed, litter sizes from Aire-KO males are possibly 
reduced compared to WT controls, but not significant as only a small number could be 
evaluated (Figure 3.1C).  
 
Evaluation of gonadotropins, testosterone and caudal sperm quantity in male Aire-
deficient mice. 
 
To assess possible endocrine disruptions related to infertility, we measured serum 
concentrations of LH, FSH and testosterone from Aire-KO males and wild type controls. 
Aire-KO male mice maintain levels of serum LH and FSH comparable to controls 
(Figure 3.2A, B); however, they have a significant reduction in circulating testosterone 
(Figure 3.2C). In a second set of animals, the numbers of sperm recovered from the 
caudal section of the epididymis was comparable between genotypes (Figure 3.2D).  
 







Figure 3.1: Aire deficiency impairs male fertility. (A) Mean percentage of WT 
controls and Aire-KO males that produced a copulatory plug. (B) Mean percentage of 
WT and Aire-KO males that generated a viable litter. (C) Mean number of offspring 
resulting from successful pregnancies. WT, wild type; KO, AIRE-deficient mice. *, P < 















































































Figure 3.2: Evaluation of gonadotropins, testosterone and caudal sperm quantity 
in male Aire-deficient mice. (A) Mean values for serum luteinizing hormone. (B) Mean 
values for serum follicle stimulating hormone. (C) Mean values for free serum 
testosterone. (D) Mean values for capacitated sperm adjusted by caudal weight. WT, 
wild type; KO, AIRE-deficient mice; LH, Luteinizing hormone; FSH, Follicle Stimulating 
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Reproductive tract abnormalities within male Aire-KO mice. 
 
We next performed histopathological evaluation of male reproductive tract tissues in 7-
16 week old males. Gross morphology and tissue weight was comparable between 
genotypes, with the exception that five of 23 Aire-KO males (22%) had combined 
testicular weight that was significantly reduced as compared to both WT controls and 
remaining 78% of Aire-KO males (Figure 3.3A, B). Histologic evaluation revealed 
severe oligozoospermia and in two of the five animals, a mild intertubular lymphocytic 
infiltrate (Figure. 3.3A). The few remaining germ cells had a rounded morphology and 
demonstrated Ki67 positive nuclei, but were displaced from the basal regions of the 
seminiferous tubules (Figure 3.3A). This was confirmed by quantifying the Ki67+ cells 
within the tubules: the mean number of Ki67+ germ cells/tubule was significantly 
reduced in Aire-KO males compared to controls (Figure 3.3C). Interestingly, even in the 
testis sections from Aire-KO mice without overt loss of germ cells, there were still fewer 
Ki67+ cells per tubule. Finally the blood-testis-barrier was disrupted in oligozoospermic 
testis samples, as evidenced by sporadic detection of the tight junction marker ZO-1 
along the basement membrane of the seminiferous epithelium, as compared to the 













Figure 3.3: Oligospermia in a subpopulation of Aire-KO male mice. (A) 
Representative images comparing whole testis, H&E sections, Ki67 staining and ZO-1 
staining between WT controls and Aire-KO males with oligozoospermia. (B) Mean 
values for the combined testis weight of WT controls, Aire-KO mice without clear 
oligospermia and Aire-KO mice with oligospermia. (C) Mean value of Ki67 positive germ 
cells per tubule from five random 20x fields per section from WT controls (n=3) and 
Aire-KO (n=5) mice. All images are 200x. Arrow head, inflammatory cells; WT, wild type; 
KO, AIRE-deficient mice; H&E, Hematoxylin and Eosin; LyCe, Leydig cells; SeTu, 
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In 15 of 22 mice Aire-KO mice (68%), epididymal sections revealed an increase in 
interstitial lymphocytic aggregates, whereas this was not detected in any WT samples.  
This held true even if epididymal gross morphology appeared normal, and if epididymal 
sperm was present (Figure 3.4 A, B). A complete absence of epididymal sperm was 
observed in six mice, all of whom displayed an abnormal interstitial morphology (Figure 
3.4 A, B) characterized by an increase in intertubule space and fibrosis within the 
caudal region (Figure 3.4B). Morphology of the seminal vesicle was unaltered and a 
mild lymphocytic infiltrate within the surrounding connective tissue was document in 16 
of 19 Aire-KO mice (84%) (Figure 3.4C). Finally, we confirmed the presence of 
pronounced prostatitis in 17 of 19 (89%) of our Aire-KO mice (Figure 3.4D), as reported 
previously (Gavanescu et al., 2008; Hou et al., 2009).  
 
Loss of vomeronasal organ-associated glands in male Aire-KO mice.  
 
Autoimmune disruption of the vomeronasal organ (VNO) could inhibit pheromone 
detection in male Aire-KO mice and explain the absence of normal mating behavior 
seen in 6 of 11 (54%) mice. To that end we evaluated the histopathology of the VNO 
and its associated glands (Figure 3.5A). Although we did not detect any morphologic 
alteration or lymphocytic infiltration within the VNO, we did observe a pronounced 
alteration to the mucus secreting glands associated with this organ in six of seven 
(86%) of Aire-KO mice (Figure 3.5B, C).  
 
 







Figure 3.4: Male Aire-KO mice can develop reproductive tract abnormalities. (A-B) 
Histopathology of the morphologic changes in the caput and cauda of the epididymis. 
(C-D) Histopathology of the seminal vesicle and prostate. All images are 200x. Arrow 
head, inflammatory cells; *, Epididymal tubules devoid of spermatozoa; WT, wild type; 
KO, AIRE-deficient mice; A, Ampulla; AP, Anterior Prostate lobe; EpTu, Epididymal 
tubules; H&E, Hematoxylin and Eosin; LoCo, loose connective tissue; MuFo, mucosal 
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Figure 3.5: Loss of Vomeronasal organ-associated glands in male Aire-KO mice. 
(A) Histology of the vomeronasal organ from WT and Aire-KO male mice at 200x 
magnification. (B) Histology of the VNO-associated glands at 40x magnification. (C) 
Percent of mice with intact VNO-associated glandular architecture. WT, wild type; KO, 
AIRE-deficient mice; H&E, Hematoxylin and Eosin; NaBo, Nasal bone; ReEp, 
Respiratory epithelium; VNO, Vomeronasal organ; VoNe, Vomeronasal 
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Autoimmune recognition of the male Aire-KO mouse reproductive tract.  
 
We confirmed the presence of T cells within the immune infiltrates identified by 
hematoxylin and eosin staining (Figure 3.3A, Figure 3.4) by probing sections of testis, 
epididymis, seminal vesicle and prostate with an anti-CD3 antibody. T cells density, 
while variable both between individual mice and differing organs, was more abundant in 
Aire-KO animals. In testis of Aire-KO mice, T cells were relatively sparse compared to 
other tissues examined, and were predominantly contained within the intertubular 
space. However, occasional CD3+ T cells were identified within the lumens of 
seminiferous tubules that were devoid of germ cells (Figure 3.6A). Epididymal T cell 
populations in Aire-KO mice were detected within all organ segments and had infiltrated 
both the interstitial space, often in aggregates, as well as the ductal epithelium (Figure 
3.6A). T cell aggregates within the seminal vesicle of Aire-KO mice were contained to 
the loose connective tissue that supports the mucosal folds (Figure 3.6A). Finally, our 
Aire-KO mice displayed a pronounced T cell infiltration into the glandular epithelium of 
the prostate comparable to what was shown by Hou et al (Figure 3.6A).  
To determine the spectrum of autoantibodies targeting the male reproductive tract 
produced as a result of Aire deficiency, we probed immunoblots of reproductive tract 
tissue lysates with the serum of Aire-KO or WT mice (Figure 3.6B). The pattern and 
strength of reactivity among animals as well as different tissues was varied. However, 
serum from Aire-KO animals consistently revealed target bands of ~42, 50 and 58 kDa 
within both the testis and the epididymal lysate. 
 







Figure 3.6: CD3+ T cell distribution and the identification of autoantibodies 
throughout the reproductive tract of Aire-KO males. The presence of an immune 
response within the reproductive tract of male Aire-KO mice was confirmed by detecting 
both CD3+ T cells and serum autoantibodies. (A) Immunohistochemical staining for the 
presence of CD3+ T cells within the male reproductive tract and associated sex glands. 
(B) From left to right: Rag-KO protein lysate from testis, caput, cauda, seminal vesicle 
and the prostate gland were probed with serum from WT and Aire-KO mice. In each 
blot, columns 1-5 contain WT serum, 6-12 contain Aire-KO serum from mice >20 weeks 
of age and 13-20 contain Aire-KO serum from mice 7-8 weeks of age. All images are 
400x. WT, wild type; KO, AIRE-deficient mice; Rag-KO, Recombinase Activation gene-1 
deficient mice; AP, Anterior Prostate lobe; EpTu, Epididymal tubules; LoCo, loose 
connective tissue; MuFo, mucosal folds; Se, secretions; SeTu, Seminiferous tubules; 
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Additionally, age of the animals had a clear effect on autoantibody production, as both 
the number and intensity of bands was greater when probing with the serum from mice 
older than 20 weeks. Reactivity against the prostate was the strongest, had limited 
variability and was present in nearly all serum samples regardless of age. In 
comparison, reactivity against the testis, epididymis and seminal vesicle displayed 
weaker reactivity, was rare in young animals (37.5% for testis and epididymis and 25% 
for seminal vesicle), but often displayed a broader spectrum of epitope recognition.  
 
Aire-KO mice generate sperm-specific antibodies and demonstrate low in vitro 
fertilization success. 
 
We investigated the possibility that anti-sperm antibodies were contributing to the 
infertility in Aire-KO mice. To confirm a fertility defect at the level of the sperm, we used 
isolated and capacitated caudal sperm to fertilized oocytes from superovulated WT 
females. Fertilization with WT sperm produced 2-cell and blastocyst stage embryos with 
a success rate of 54% and 40%, respectively. However, sperm from Aire-KO males had 
only a 9% success rate in creating 2-cell embryos, and embryos never progressed to 
the blastocyst stage (Figure 3.7A). Next anti-sperm antibodies were detected in serum 
from Aire-KO mice by probing a lysate of caudal sperm by western blot. Of 15 serum 
samples from Aire-KO mice, 11 (73%) contained sperm-specific antibodies that 
recognized autoantigens of comparable size to those detected in whole testis and 
epididymal lysates (Figure 3.6B, 3.7B). Binding of autoantibodies to sperm was 
confirmed by probing frozen tissue sections of caudal epididymis from a Rag-deficient 







Figure 3.7: In vitro fertilization with Aire-KO male sperm and localization of anti-
sperm/anti-epididymal autoantibodies. (A) Percent of oocytes incubated with sperm 
from WT and Aire-KO mice to reach both 2-cell and blastocyst stage. (B) Rag-KO 
sperm protein lysate probed with individual serum samples from five WT and 15 Aire-
KO mice. (C) From left to right: WT serum on a frozen Rag-KO caudal section, Aire-KO 
serum on a frozen Rag-KO caudal section, FITC anti-Mouse IgG on frozen Aire-KO 
caudal section. All images are 40x. Arrows indicate selected samples used for Fig. 
2.7C. WT, wild type; KO, AIRE-deficient mice; EpTu, Epididymal tubules; Rag-KO, 
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mouse with selected serum samples (arrow heads) (Figure 3.7C). Compared to WT 
mice, autoantibodies within Aire-KO serum localized to the epithelium and connective 
tissue surrounding the epididymal tubules (all samples) as well as with caudal sperm 
(three of four). Finally, to determine whether endogenous antibodies bound tissue in 
situ, caual sections were subjected to direct immunofluorescence using a FITC-
conjugated anti-mouse IgG antibody (Figure 3.7C). While the presence of anti-sperm 
autoantibodies was not detected, prominent IgG deposits marking the epithelium and 
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DISCUSSION 
 
Disruption of AIRE in both humans and mice impedes the establishment of 
central immune tolerance and produces a multi-organ autoimmunity characterized by 
the presence of autoreactive T cells and antibodies (Aaltonen et al., 1997; Anderson et 
al., 2002). While discrepancies in both the disease severity as well as the profile of 
target organs exist between APS-1 patients and Aire-deficient mouse models, a shared 
pathology is premature gonadal insufficiency (Anderson et al., 2002; Hubert et al., 2009; 
Kuroda et al., 2005; Perheentupa, 2006; Ramsey et al., 2002). We have previously 
demonstrated that one cause of early reproductive senescence in female mice on the 
Balb/c genetic background is an age-dependent loss of ovarian follicular reserves 
beginning at three  months of age (Jasti et al., 2012). However, information on fertility 
and reproductive immune targets in male Aire-deficient mice remains scattered and 
exiguous. In this study we demonstrate that the majority of male Balb/c Aire-KO mice 
are infertile, produce low levels of testosterone, develop autoimmune recognition 
against the male reproductive tract, have structurally abnormal glands associated with 
the vomeronasal organ and generate sperm with a severely reduced potential to fertilize 
an oocyte in vitro. Additionally, roughly one fifth of Aire-KO male mice are 
oligozoospermic with an apparent disruption of the blood-testis-barrier.  
Gonadal insufficiency occurs in approximately 12-14% of male APS-1 patients 
(Ahonen et al., 1990) with the vast majority of cases being diagnosed with primary 
hypogonadism due to low testosterone levels. Only one case of hypogonadotropic 
hypogonadism (Ahonen et al., 1990), which is common in female patients, has been 
reported in male APS-1 patients, suggesting that the autoimmune lesions of infertility 
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differ between sexes. However, the majority of both males and females develop anti-
steroid cell antibodies specific for 17α–hydroxylase (Krohn et al., 1992), 21-hydroxlase 
(Uibo et al., 1994) and P450 side-chain cleavage (Winqvist et al., 1995).  
Our analysis of the infertility in male Balb/c Aire-KO mice mirrors the constellation 
of symptoms observed in infertile APS-1 males. These mice are almost completely 
infertile, have low testosterone, and normal production of gonadotropins. Preliminary 
observations show histologically normal pituitary glands with no lymphocytic infiltration 
(unpublished). Interestingly, over half of the animals did not mate over a three-week 
period (Figure 3.1). The low testosterone (Figure 3.2) might be one potential cause, but 
another possibility is a disruption of vomeronasal organ function. The VNO is a 
component of the accessory olfactory system whose sensory neruoepithelium is 
responsible for detecting pheromones and is one of only two locations that express the 
odorant binding protein 1a (OBP1a). OBP1a is expressed in an Aire-dependent manner 
within the thymus presumably to provide antigen tolerance to the presumptive 
pheromone transporter (Bocskei et al., 1992; J. J. DeVoss et al., 2010; Pes et al., 
1998). An autoimmune response against OBP1a, along with the ubiquitous antigen α-
fodrin, has been shown to induce autoimmune dry eye and the destruction of the 
salivary and lacrimal glands of Aire-deficient mice resulting in condition similar to 
Sjögren’s Syndrome (J. J. DeVoss et al., 2010). Histopathologic evaluation of the VNO 
in our mice revealed no direct inflammation; however, we did discover an alteration to 
the associated glands (Figure 3.5). Many of the sub-epithelial tubuloacinar glands 
secrete a mucous directly into the lumen of the VNO (Salazar, Quinteiro, & Cifuentes, 
1997). The glandular secretions are responsible for dissolving various chemical 
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pheromone stimuli, transporting them to the VNO and removing them following 
chemoreception (Mendoza & Breipohl, 1983; Mendoza & Kuhnel, 1987; Roslinski, 
Bhatnagar, Burrows, & Smith, 2000). In humans the function of the VNO as a sensory 
organ is unclear (Trotier et al., 2000). However, pheromone detection through the VNO 
has been shown to be an essential component of mating behavior for sexually 
inexperience hamsters (Meredith, 1986) and its surgical removal, particularly in young 
mice, results in major behavioral changes to courtship, sexual behavior, aggression and 
the onset of puberty (Wysocki & Lepri, 1991). Further, male old world primates have 
been shown to demonstrate a behavior similar to the flehman response (Estes, 1972) 
when exposed to odorants from cycling females (Charpentier, Mboumba, Ditsoga, & 
Drea, 2013). It is possible that the changes to the VNO-associated glands results in a 
secondary disruption of the VNO in our sexually inexperienced male mice that impairs 
their mating behavior resulting in the presence of fewer copualtory plugs.  
Aire-deficient mice have been shown to develop immune autoreactivity against 
multiple organs including, but not limited to, the eye, stomach, pancreas, ovaries and 
salivary glands (Anderson et al., 2002; Jasti et al., 2012; Jiang et al., 2005). With 
regards to the male reproductive tract, the existence of anti-testis and anti-prostate 
autoantibodies has been documented (Hou et al., 2009; Hubert et al., 2009; Ramsey et 
al., 2002). However an analysis of the inflammation occurring within the testis, 
epididymis or seminal vesicle has not been completed. Inflammation, both systemic 
(Kalyani et al., 2007) and local, can impair male fertility. In general, epididymitis is the 
most common male reproductive tract inflammatory disease (Luzzi & O'Brien, 2001); 
impacting over 600,000 US males annually (Krieger, 1984), and can lead to secondary 
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involvement of the testis. This paradigm is replicated in our Aire-KO mice in which 22% 
(Figure 3.3) of the male mice evaluated were oligozoospermic with evidence of acute 
testicular inflammation. However, 68% of animals had either ongoing inflammation 
(Figure 3.6) or increase fibrosis suggesting a previous inflammatory event (Figure 3.4) 
within the epididymis, suggesting that the epididymis is the initial target of the immune 
system in Aire-deficient mice.   
Interestingly, the histopathology of the oligozoospermic animals resembled a 
Sertoli cell only syndrome. First described in 1947 (Del Castillo, Trabucco, & FA, 1947), 
the syndrome is characterized by a testis biopsy that demonstrates a complete absence 
of germ cells with an otherwise normal seminiferous epithelium. The syndrome is the 
leading cause of non-obstructive azoospermia in infertile males and believed to derive 
from microdeletions within the azoospermia factor (AZF) region of the Y-chromosome 
(Foresta et al., 1998; Kamp et al., 2001; Reijo et al., 1995). Here, we show for the first 
time that an immune response can also cause a total depletion of germ cells. While the 
molecular mechanism leading to the Steroli cell only phenotype in our Aire-KO mice 
remains unclear, one possibility is disruption of the blood-testis-barrier secondary to 
inflammation (Koksal et al., 2007). Sertoli cells respond to both autocrine and paracrine 
cytokine signaling to alter their adhesive proprieties to facilitate the transport of 
preleptotene/leptotene spermatocytes past the blood-testis barrier (BTB) (Xia, Mruk, 
Lee, & Cheng, 2006). It is possible that inflammatory cytokine signaling in our 
azoospermic mice alters the Sertoli cells, as suggested by the loss of consistent ZO-1 
expression (Figure 3.3), such that they are no longer able to retain developing 
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spermatogonia behind the BTB and consequently exposing highly immunogenic sperm 
antigens to the immune system.  
Chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS) in men is a 
common condition and unfortunately not well understood. Patients present urologic 
symptoms, nonspecific discomfort in the pelvic region and sexual dysfunction (R. B. 
Alexander & Trissel, 1996). Despite initial speculation that these disorders had a 
bacterial etiology, it is now believed that the majority of CP/CPPS cases have 
noninfectious origins (de la Rosette, Hubregtse, Meuleman, Stolk-Engelaar, & 
Debruyne, 1993; Krieger & Egan, 1991). Importantly, the presence of prostatic immune 
aggregates is common (Kohnen & Drach, 1979; Theyer et al., 1992) and further, it has 
been demonstrated that a percentage of CP/CPPS patients have the ability to generate 
a proliferative T cell recall response when challenged with seminal plasma (Alexander, 
Brady, & Ponniah, 1997), both of which suggest a potential autoimmune component to 
CP/CPPS.  
Aire-deficient mice evaluated on a mixed (129/Sv x C57BL/6) F2 genetic 
background have been shown to develop spontaneous immune response against the 
prostate autoantigen seminal vesicle secretory protein 2 (SVS2) (Hou et al., 2009). The 
result was a moderate to severe prostatitis in over 70% of the mice. We have confirmed 
this results in nearly 90% of our animals on a congenic Balb/c background (Figure 
3.4D, 3.6A). Background genetics has a significant influence on the severity of disease 
and the range of autoantigens targeted in mouse models of Aire-deficiency (Jiang et al., 
2005). However, some target organs, as is the case for the prostate, are consistent 
across strains. Interestingly, the dominant prostate antigens in Aire-deficient Balb/c 
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mice were not SVS2, but instead a higher molecular weight protein, identification of 
which is currently underway (Figure 3.6B and work in progress). Nevertheless, we 
contend that a deficiency in Aire, along with day-3 thymectomy (Taguchi et al., 1985), 
are good models for the study of chronic autoimmune prostatitis.  
Mature spermatozoa contain numerous specific proteins (Suri, 2004) that are 
potentially immunogenenic in both men and women. However, the consequence of an 
immune response resulting in the production of anti-sperm antibodies its contribution to 
infertility remains unclear. It is estimated the sperm autoantibodies, which can form 
following trauma, inflammation or vasectomy (Meinertz, Linnet, Fogh-Andersen, & Hjort, 
1990), are present in seven to 28 percent of infertile males compared to less than two 
percent of healthy men (Haas, Cines, & Schreiber, 1980; Heidenreich et al., 1994). 
These antibodies are considered clinically important when over 50% of the spermatozoa 
are coated with IgG and IgA antibodies which can block sperm penetration (Eggert-
Kruse, Leinhos, Gerhard, Tilgen, & Runnebaum, 1989) and decrease in vitro fertilization 
rates (Clarke, Lopata, McBain, Baker, & Johnston, 1985). 
Hubert et al. (2009) speculated that anti-sperm autibodies are a causative agent 
for the decreased fertility Aire-deficient males on the B6 background (Hubert et al., 
2009). In our evaluation we demonstrated significantly lower IVF success rates, with 
only 9% of wild-type oocytes developing to the two-cell stage, and none reaching the 
blastocyst stage, after being incubated with epididymal sperm from Balb/c Aire-deficient 
mice (Figure 3.7A).  It is possible that the observed orchido-epididymitis is impacting 
the health and quality of the developing sperm such that they have a reduced potential 
to fertilize an oocyte. While we documented serum antibody reactivity against sperm 
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protein in the majority of our animals (Figure 3.7B, C), we did not detect the presence 
of these autoantibodies in situ within the caudal region of the epididymis (Figure 3.7C). 
We did, however, note considerable autoantibody binding to the basal epithelium of the 
epididymal tubules (Figure 3.7C). The secretory products of the epididymal epithelium 
contribute to the completion of sperm development, enhancement of motility and the 
ability to bind the zona pellucida (Kirchhoff, Osterhoff, Pera, & Schroter, 1998; Moore, 
Curry, Penfold, & Pryor, 1992). It is possible that the abundant antibody deposition 
within the epididymis is altering the ability of the tubule epithelial cells to transport and 
secrete the requisite seminal plasma proteins for complete spermatozoa development 
and thus impairing their fertilization potential.  
The discovery of Aire and its ability to regulate expression of tissue specific 
antigens within the thymus has shifted our understanding of the mechanisms behind 
immune tolerance. In this study, we show that a deletion of Aire results in wide spread 
recognition and inflammation within the male reproductive tract that is associated with 
decreased fertility. The correlation between impaired central immune tolerance and 
fertility has potential implications for not only male APS-1 patients but may also provide 
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MODEL 
 The original dogma concerning the mechanisms of central immune tolerance for 
self-antigens has been forever changed by the discovery of the Autoimmune Regulator 
(AIRE) gene (Nagamine et al., 1997). AIRE-regulated gene expression within the 
medullary compartment of the thymus results in the expression of several thousand 
genes against which autoreactive thymocytes are negatively selected (Anderson et al., 
2002; Derbinski et al., 2001). Importantly, an estimated 25% of the AIRE-regulated 
genes are highly restricted in their peripheral tissue distribution, suggesting that central 
tolerance controls autoimmune disease against both ubiquitous and tissue specific 
antigens (Anderson et al., 2002; Derbinski et al., 2005).  
 Our current understanding of the function of AIRE is modeled in Figure 4.1. 
AIRE induced gene expression provides a pool of antigens that are presented to 
developing T cells within the medulla of the thymus. T cells that demonstrate a high 
affinity for both restricted and ubiquitous self-antigens are negatively selected to prevent 
the release of self-specific naive T cells. Alternatively, non-self specific T cells are 
allowed to complete their maturation and provide immune surveillance within the 
periphery (Figure 4.1A). Mutations to AIRE prevent this selection process and as a 
consequence allow the escape of self-antigen specific T cells that can incite numerous 












Figure 4.1: Model of AIRE-regulated gene expression for central immune 
tolerance. (A) AIRE-regulated gene expression within the thymic medulla provides an 
antigen source against which self-reactive T cells are negatively selected and removed 
to prevent autoimmune disease. (B) A disruption of the AIRE gene prevents the 
expression of numerous self-antigens. Autoreactive T cells that would otherwise have 
been removed are now allowed to escape the thymus and instigate multiple 
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The collection of AIRE regulated antigens includes several that are expressed 
within the male and female reproductive tracts. Expectedly, many of these genes are 
abundantly expressed throughout most tissues, but there are several proteins that are 
highly specific for the reproductive system. Selected female reproductive system 
specific genes include: aldehyde dehydrogenase family 1 (ALDH1A7), angiopoietin 4 
(Ang4), amphiregulin (AREG), AU020206, branched chain aminotransferase 1 
(BCAT1), cyclin dependent kinase inhibitor 1C (CDKN1C), embryonic hemoglobin Y 
(HBB-Y), Keratin 16 (KRT1-16) and zona pellucida 3 (ZP3) (Derbinski et al., 2005). 
Selected male reproductive tract specific examples include: DNA binding protein 
Obfc2a, Rab GTPase Tbc1d3, CD55 antigen (DAF1), glutathione S transferase mu 5 
(GSTM3) and lactate dehydrogenase C (LDH3). Regardless of the inciting antigen, 
AIRE-mediated central immune tolerance is essential for fertility perseveration in both 
men and women (Aaltonen et al., 1997; Ahonen et al., 1990; Anderson et al., 2002; 
Nagamine et al., 1997). Our study of the specific immune targets leading to infertility in 
Aire-deficient mice advances our understanding of autoimmune infertility.  
 
AUTOIMMUNE PRIMARY OVARIAN INSUFFICIENCY 
 Primary ovarian insufficiency (POI), previously known as “premature menopause” 
or “premature ovarian failure”, is the development of hypergonadotropic hypogonadism 
in women with a normal karyotype under the age of 40 (Nelson, 2009). The overall 
incidence of spontaneous POI is roughly 1 in 250 for females under 35 and 1 in 100 for 
women under 40 (Coulam, Adamson, & Annegers, 1986). POI is characterized by low 
serum estrogen, gonadotropin levels typically associated with menopause and either 
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oligomenorrhea (infrequent menstruation) or amenorrhea (absence of menstruation). In 
approximately 4% of women with spontaneous POI, the pathogenesis is thought to 
derive from autoimmune oophoritis (Bakalov et al., 2005; Hoek et al., 1997). 
Autoimmune POI was first confirmed in 1968 and often presents in association with 
autoimmune adrenal insufficiency (Irvine et al., 1968). The co-existence of ovarian and 
adrenal disease is likely due to their overlapping function as steroidogenic organs. 
Indeed, testing for anti-steroid cell antibodies is often done in women suspected for 
autoimmune POI (S. Chen et al., 1996; Falorni et al., 2002; Sotsiou, Bottazzo, & 
Doniach, 1980). Additionally, autoimmune POI can present in combination with the 
Autoimmune Polyglandular Syndrome Type I (APS-I). Patients with APS-I, due to a 
deficiency in AIRE, develop a multi-organ autoimmune syndrome that preferentially 
targets endocrine organs, including the ovary. Oophoritis secondary to APS-I occurs in 
approximately 60% of female patients by the age of 30 (Ahonen et al., 1990). 
Unfortunately, the precise mechanisms driving the immune response against the ovary 
remain unknown (Nelson, 2001).  
 Previous work from our lab has shown that the ovaries of Aire-deficient mice are 
highly immunogenic, resulting in complete follicular loss in nearly 60% of animals by 12 
weeks of age (Jasti et al., 2012). Additionally, the primed immune systems of Aire-KO 
mice demonstrate a powerful memory response when challenged with a grafted wild-
type ovary (Figure 2.1). We have now shown that the abnormal trafficking of leukocytes 
to the ovaries, which can occur as early as three-weeks of age, is likely responsible for 
impaired fertility in mice prior to complete follicular senescence. Our data suggests that 
the consequence of this early immune response is an increase in degenerated oocytes 
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at ovulation (Figure 2.7B), smaller implantation sites at embryonic day (ED) 5.5 (Figure 
2.6A, C), delayed in vitro and in vivo embryo development (Figure 2.7C,D and Figure 
2.8A, B), reduced trophoblast outgrowth (Figure 2.8C) and complete embryo loss in 
50% of animals by ED7.5 (Figure 2.3A).  
 I have previous discussed our current hypothesis; that the early inflammatory 
events within the ovary result in low quality oocytes that can be fertilized but fail to 
progress through development on a synchronized timeline with the uterine environment. 
The result is a significantly elevated rate of post-implantation embryonic loss. But what 
drives the oophoritis and what are the changes occurring within these doomed oocytes 
that prevent them from maintaining a viable pregnancy?  
Initially we hypothesized that hormonal defects and autoantibody depended 
pathology were responsible for the fertility lesion in Aire-KO female mice. Support for 
this derived from that fact that women with autoimmune POI, as well as APS-I 
preferentially produced antibodies that are steroid cell specific (Dal Pra et al., 2003; 
Soderbergh et al., 2004; Welt, 2008). Additionally, autoantibodies can result in fetal 
demise. The best-documented example of this comes from the anti-phospholipid 
syndrome (APS), in which women develop anti-phospholipid antibodies leading to 
vascular thrombosis and several pregnancy morbidities (Branch & Khamashta, 2003; 
Lima et al., 1996; Wilson et al., 1999). Interestingly, we found that progesterone 
production was unaffected (Figure 2.3C) and were unable to detect the presence of 
unique antibodies specific for the uterus, embryo or placenta (Figure 2.4). These 
negative results suggest that a hormonal deficiency and female reproductive 
autoantibodies are not respsonbile for the infertility in Aire-KO mice. However, additional 
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experiments including progesterone supplementation in previously oophorectomized 
animals and serum transfer from Aire-KO mice into pregnant WT controls may be 
required to completely exclude these possibilities.    
Isolating the inciting antigen is an essential step in uncovering the etiology of an 
autoimmune disorder. Unfortunately the pathogenesis of spontaneous autoimmune POI 
remains unknown. The most common speculation is molecular mimicry (Garza & Tung, 
1995; Luo et al., 1993). A prior immune response against a viral antigen that is 
structurally similar to an ovarian antigen could result in subsequent oophoritis. One 
significant aspect of the Aire-deficient mouse model is that it provides an opportunity to 
discover the ovarian antigen(s) capable of driving an immune response. Current 
unpublished work from Dr. Cheng at the University of California, San Francisco has 
suggested that the antigen has a high molecular weight. Similarly, we have 
demonstrated the presence of autoantibody reactivity against ovarian antigens > 75 kDa 
in 60% (9 of 15) of animals tested (Figure 2A). An important next step will be to identify 
these antigens by either mass spectrometry or sequencing the T cell receptors from a 
clonal population of Aire-KO T cells stimulated with ovarian lysate.  
Once the instigating antigen has been determined, it will be important to assess 
what inflammatory-mediated changes are occurring within the oocyte that results in 
developmental delay of the embryo and peri-implantation infertility. We are currently 
developing a mating strategy that will allow us to identify infertile Aire-KO female mice. 
This design will allow us to selectively isolate RNA for sequencing from oocytes that are 
otherwise incapable of sustaining a successful pregnancy. Importantly, this effort should 
allow us to identify global gene changes downstream of ovarian inflammation. This will 
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provide a significant contribution to our understanding of the mechanisms behind 
autoimmune primary ovarian insufficiency.  
 
IDIOPATHIC MALE INFERTILITY 
 Nearly one couple in five will seek medical advice for infertility (Chandra, 2013; 
Mahmoud, 2000; Slama et al., 2012). Often the etiology is related to an ovulatory 
disorder or semen abnormality. Unfortunately, 15% of infertility cases remain 
unexplained (Collins & Crosignani, 1992; Templeton & Penney, 1982). This is 
particularly important for male patients. The biology governing male fertility, beginning 
with spermatogenesis and concluding with timed intercourse, is very complex and many 
components are still not fully understood. As a result, in 40% of male infertility cases, 
even when a dysfunction can be identified, the cause remains unclear (de Kretser, 
1997; Dubin & Amelar, 1971). Recent advances in our understanding of the genetics 
behind male fertility have improved these odds. Two important examples include the 
discovery of mutation to the cystic fibrosis transmembrane conductance regulator 
(CFTR) gene and Y chromosome microdeletions impacting the “deleted in 
azoospermia” (DAZ) gene (Reijo et al., 1995; Riordan et al., 1989). These genetic 
abnormalities are present in 1-2% and 10-20% of male infertility patients respectively 
(Jequier, Ansell, & Bullimore, 1985; Najmabadi et al., 1996). However, it remains clear 
that more work needs to be done.  
 Perhaps one hindrance preventing a greater drive to uncover the causes of 
unexplained male infertility is the success of two assisted reproductive techniques: in 
vitro fertilization (IVF) and intra cytoplasmic sperm injection (ICSI). These two 
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interventions provide the highest success rate in the shortest amount of time. The first 
live birth from IVF was recorded in 1978 (Steptoe & Edwards, 1978). Since then more 
than 4 million pregnancies have resulted from IVF. Similarly, the first report of a clinical 
pregnancy resulting from the injection of a single sperm from an infertile male into a 
female gamete occurred in 1993 (Van Steirteghem et al., 1993). While the success of 
ICSI can vary depending on the protocols used and the specific male disorder being 
treated (De Croo, Van der Elst, Everaert, De Sutter, & Dhont, 2000; Mantikou et al., 
2013; Schiff et al., 2005), the reported live birth rates per treatment cycle and per 
patient are 24% and 60% respectively (Witsenburg, Dieben, Van der Westerlaken, 
Verburg, & Naaktgeboren, 2005).  Further, compared to other assisted fertility protocols, 
IVF has the greatest documented success rates for males with unexplained infertility 
(Goldman et al., 2014; Pandian et al., 2012).  
However, it should be noted that these options are not without consequence. 
Two primary issues regarding IVF/ICSI include their substantial cost and ethics. IVF and 
ICSI are the most financially prohibitive assisted reproductive interventions, with 
average cost between 10,000 and 15,000 dollars per treatment cycle. Additionally, 
concerns have been raised regarding the speed at which these techniques have 
advanced, often without accompanying progress in the knowledge of the underlying 
disorders (Cummins & Jequier, 1995). At the forefront of these ethical debates are 
topics concerning the increased frequency of sex chromosome abnormalities in children 
born from ICSI (Tournaye et al., 1995) as well as how to handle unused or abandoned 
embryos following a successful pregnancy from these interventions ("Disposition of 
abandoned embryos: a committee opinion," 2013).  
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Our investigation into the cause of infertility in male Aire-deficient mice has 
yielded an opportunity to advance our understanding of the impact of several 
autoimmune disorders on male fertility. We have shown that Aire-KO male mice have a 
significant reduction in both their frequency of mating (Figure 3.1A) as well as their 
fertility (Figure 3.1B). Unlike Aire-deficient female mice, whose infertility appears to 
derive from the effects of autoimmune oophoritis, the infertility in males appears to be 
multi-factorial. The potential sources of male infertility include low testosterone (Figure 
3.2C), lack of female pheromone detection (Figure 3.5), reproductive tract inflammation 
(Figure 3.4, 3.6), oligozoospermia (Figure 3.3) and impaired fertilization (Figure 3.7A).  
Chemosensory detection of female pheromones is an important aspect of 
initiating male mating behaviors in many animal species (Fiber, Adames, & Swann, 
1993; Meredith, 1986; Wysocki & Lepri, 1991). In rodents the accessory olfactory 
system, which includes the vomeronasal organ (VNO), is responsible for recognizing 
these environmental cues and initiating a neuronal response leading to mating behavior 
(Halpern, 1987; Stowers, Holy, Meister, Dulac, & Koentges, 2002). It is very possible 
that the destruction of the VNO-associated mucus glands seen in the majority of Aire-
KO male mice (Figure 3.5) inhibits this behavioral pathway resulting in decreased 
mating frequency. 
A second unexplored possibility is that the extensive inflammation within the 
region of the male reproductive tract containing the prostate, the ampullary gland and 
the vas deferens is somehow altering the non-sperm components of the male ejaculate. 
In internally fertilizing species, the various proteins of seminal plasma have been shown 
to alter several aspects of reproduction including the female immune response to both 
	   160	  
male and female gametes, female receptivity and embryo implantation (Chen et al., 
1988; Robertson, 2007; Rodriguez-Martinez, Kvist, Ernerudh, Sanz, & Calvete, 2011). 
Further, in many species the seminal proteins will coagulate and harden into a 
copulatory plug within the female cervix (Dixson & Anderson, 2002; Ramm, Parker, & 
Stockley, 2005). While the biology of plug formation is still being investigated, it has 
been shown that a prostate-specific transglutaminase is required for coagulation 
(Williams-Ashman, Notides, Pabalan, & Lorand, 1972). Importantly, evaluation of male 
fertility in our experiments relied on the detection of a copualtory plug. It is very possible 
that our male Aire-KO mice were in fact mating, but were unable to effectively fertilize a 
female due to autoimmune mediated alteration of the seminal components required for 
copulatory plug formation. In order to distinguish between a behavioral versus 
copulatory plug formation defect, it may prove necessary to record our animals when 
paired for breeding. 
However, the severe autoimmune prostatitis seen in nearly all our male Aire-
deficient mice (Figure 3.4, 3.6) might be resulting in enough pain and discomfort to 
dissuade any mating events from occurring. Indeed, chronic prostatitis/chronic pelvic 
pain syndrome, which affects approximately 2-10% of all adult males worldwide, is 
associated with male infertility (Krieger, Riley, Cheah, Liong, & Yuen, 2003; Rusz et al., 
2012). Although poorly understood, one proposed mechanism is that inflammatory 
molecules present within prostatic fluid induce oxidative stress that impairs sperm 
motility and function (Diemer, Huwe, Ludwig, Hauck, & Weidner, 2003; Pasqualotto et 
al., 2000). Future efforts to evaluate the extent of pelvic pain as well as the cytokine and 
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leukocyte concentrations within prostatic fluid from Aire-KO mice could help advance 
our understanding of chronic autoimmune prostatitis on male fertility.  
Beyond pain syndromes and behavioral disorders, our Aire-deficient male mice 
clearly develop a fertility lesion at the level of their sperm (Figure 3.7A). Indeed, 
prostatitis and epididymitis have been shown to alter sperm morphology and function 
(Haidl, Allam, & Schuppe, 2008; Henkel et al., 2006). Further, we have detected anti-
sperm antibodies in 73% (11 of 15) of male mice (Figure 3.7B, C). As discussed above, 
antibodies reactive to sperm can prevent sperm-egg interaction and correlate with 
reduced IVF rates (Clarke et al., 1985; Eggert-Kruse et al., 1989). A vital next step in 
uncovering the cause of male infertility due to a deficiency in AIRE will be a detailed 
analysis of the mature sperm. This will include both descriptive measures (motility, 
morphology and intra-testicular sperm quantification) as well as functional evaluations 
(cervical mucosa penetration, acrosome reaction and capacitation) (Aitken, 2006).  
An autoimmune component to male infertility occurs in approximately 12-18% of 
patients (Menge, Medley, Mangione, & Dietrich, 1982; Sinisi et al., 1993). Unfortunately 
our understanding of the mechanisms that impair male fertility have not maintained 
pace with the advances in treatment options. As mentioned previously in this section, 
assisted reproductive technologies have provided new hope for males coping with 
infertility. But this does not mean that we should forgo efforts to discern the underlying 
biology. In the specific case of male hypogonadal APS-1 patients, a discovery of 
effective treatment options will likely require an understanding of how the male gamete 
has been altered by the autoimmune events occurring within the reproductive tract. In a 
broad sense, male Aire-deficient mice provide a model system from which the 
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autoimmune involvement leading to chronic prostatitis, epididymitis, olfactory defects, 
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Honors and Awards 
Year Award 
2006 George Fox University, Duke Scholarship 
2006 George Fox University, Magna Cum Laude 
2006 George Fox University, National Dean’s List 
2011 American Society for Reproductive Immunology, Outstanding New Investigator Award 
2012 University of Kansas Medical Center, Student Research Forum: 2nd basic science II 
2012 University of Kansas Medical Center, Biomedical Research Training Program 
Fellowship 
2012 Society for the Study of Reproduction, Larry Ewing Memorial Trainee Travel Fund 
2013 University of Kansas Medical Center, Paul B. Freeburg Cell Biology Award 
2013 University of Kansas Medical Center, Graduate Student School Of Medicine Award 
2013 University of Kansas Medical Center, Biomedical Research Training Program 
Fellowship 
 
RESEARCH AND SCHOLARLY ACTIVITIES:  
Scholarly Publications 
1. Jasti S, Warren BD, McGinnis LK, Kinsey WH, Petroff BK, Petroff MG. 2012. The autoimmune 
regulator prevents premature reproductive senescence in female mice. Biol. Reprod. 86(4):110. 
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Published abstracts (** denotes first author as recipient of award or selected as oral presentation): 
 
1. Warren BD, F. S. J. De Souza, V. Otero-Corchon, R. Kruse-Bend, M. Rubinstein, *M. J. Low. 2007. 
Reversible neuron-specific silencing of proopiomelanocortin (POMC) expression by targeting a loxP-
flanked neo cassette to the distal upstream enhancer region of the Pomc gene. Society for 
Neuroscience. 
 
2. A. L. Sharpe, Warren BD, V. Otero-Corchon, E. J. Kremer, F. S. J. De Souza, M. Rubinstein, M. J. 
Low. 2007. Neuroanatomical and functional mapping of hypothalamic proopiomelanocortin neurons in 
mice with a reversibly silenced Pomc gene allele by the retrograde axonal transport of a canine 
adenoviral vector expressing Cre recombinase. Society for Neuroscience.  
 
3. Warren BD**, Susmita Jasti, Brian K Petroff, and Margaret G Petroff. 2011. Auto immune regulator 
(AIRE) deficiency results in infertility involving embryonic loss in mice. American Journal of 
Reproductive Immunology.  
 
4. Warren BD, Susmita Jasti, Brian K Petroff, and Margaret G Petroff. 2012. Autoimmune Regulator 
(AIRE) deficiency is associated with embryonic loss and generation of autoantibodies against the 
uterus, placenta and embryo. Society for the Study of Reproduction.  
 
5. Warren BD, Leslie L Heckert, Timothy A Fields, Brian K Petroff, and Margaret G Petroff. 2013. The 
Autoimmune Regulator (AIRE) protects against infertility, reproductive tract inflammation and germ 




1. Warren BD, Susmita Jasti, Brian K Petroff, and Margaret G Petroff. Auto immune regulator (AIRE) 
deficiency results in infertility involving embryonic loss in mice. Platform Presentation. 31st annual 
meeting of the American Journal of Reproductive Immunology, Salt Lake City, Utah; 05/2011. 
 
2. Warren BD, Susmita Jasti, Brian K Petroff, and Margaret G Petroff. Autoimmune Regulator (AIRE) 
deficiency is associated with embryonic loss and generation of autoantibodies against the uterus, 
placenta and embryo. Platform Presentation. 45th annual meeting of the Society for the Study of 





Years (Inclusive) Title Employer 
2009-Present Ph.D Candidate  University of Kansas Medical 
Center 
Jan 2009 – Sept 2009 Research Associate  University of Kansas Medical 
Center 
May 2006 – Dec 2009 Research Assistant Oregon Health and Science 
University 
Aug 2007 – Dec 2008 Varsity Women’s Assistant 
Soccer Coach 
George Fox University 
April 2005 – May 2006 Server Outback Steakhouse 
Sept 2004 – April 2006 Biology Teaching Assistant George Fox University  
June 2002 – Aug 2004 Laboratory Technician Pathology Associates Medical 
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VOLUNTEER EXPERIENCE 
 
Years (Inclusive) Position  Organization Hours 




University of Kansas 
Medical Center 
1 hour 
2011 – 2014 IGPBS recruitment 
ambassador  
University of Kansas 
Medical Center 
25 hours 
July 2011 – Present Usher Captain Antioch Bible Baptist  56 hours 
April 2011 – Oct 2011 Lawn Care Antioch Bible Baptist 24 hours 
Feb 2011 – Aug 2012 Youth Ministry Antioch Bible Baptist 72 hours 
April 2010 Student Research 
Forum Volunteer 





Volunteer American Lung Association 5 hours 
 
April 2007 – Dec 2008 Volunteer Care Giver Private Community Service 75 hours 
Oct 2007 – April 2009 Big Brother Big Brothers and Big 
Sisters of America 
156 hours 
Sept 2003 – April 2006 Biology Tutor George Fox University 200 hours  
Sept 2002 – Sept 2003 Community Service George Fox University 16 hours 
Aug 2001 – July 2002 Emergency Room 
Volunteer 
Deaconess Medical Center 220 hours 
 
PROFESSIONAL SOCIETIES AND AFFILIATIONS  
 
Years (Inclusive) Organization  
2010 – Present American Society for Reproductive Immunology 
2011 – Present Society for the Study of Reproduction  
 
PHYSICIAN SHADOWING  
 
Years (Inclusive) Department/Organization  Physician Hours 
2013 – Present Pathology and Laboratory 
Medicine; University of 
Kansas Medical Center 
Dr. Maura F O’Neil 40 hours 
2013 – Present General Internal Medicine 
– Inpatient; University of 
Kansas Medical Center  




Date Course Instruction Type/Hours Students 
2012 – 2013 Prematriculation 
Program; KU-SOM 
Lecture: Cells of the 
Immune system (2 x 4 
hours) 
20 student/year entering the 
University of Kansas School 
of Medicine 
May 28 – May 31 2013 Frontiers in 
Reproduction; Marine 
Biological Laboratory, 
Woods Hole, MA  
Teaching Assistant (20 
hours)  
15 students including 
graduate candidates, post-
doctoral researchers and 
clinical fellows  
 
